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Summary  
The aim of the thesis was to identify cell surface proteins of the pathogenic fungus Candida 
albicans which could be used for diagnostic purposes. Additionally, regulatory pathways, 
which govern the expression of such cell surface proteins, in particular those involved in iron 
uptake, were studied.  
We applied different methods of cell surface proteins extraction and selected the ß-(1,3)-
glucosyltransferase Bgl2p as first target protein for diagnosis of C. albicans infections. Based 
on sequence homologies as well as on a modeled structure of Bgl2p, we identified a unique 14 
aa peptide from Bgl2p, against which monoclonal antibodies were produced by project 
partners. Different supernatants of hybridoma cell cultures, containing monoclonal antibodies 
directed against this peptide, could bind a recombinant version of purified Bgl2p. 
Furthermore, two of these monoclonal antibodies could bind to whole C. albicans cells in a 
manner that was most likely dependent on Bgl2p. Thus, these antibodies are promising tools 
for diagnosis of C. albicans infections.  
Multicopper ferroxidase (MCFO) proteins are cell surface components of the reductive iron 
uptake pathway (RIUP) and were isolated from whole cells by heat extraction. As MCFOs 
expression was regulated by iron availability as well as by the high osmolarity glycerol 
(HOG) pathway, we studied phenotypic and molecular responses of C. albicans to different 
iron concentrations with respect to the activity of the Hog1p mitogen activated protein (MAP) 
kinase module of the HOG pathway in particular. This thesis shows, for the first time in fungi, 
that Hog1p of C. albicans is involved in the response to changes in extracellular iron 
concentrations. Hog1p was found to have a dual role in C. albicans iron homeostasis: basal 
Hog1p activity repressed high affinity iron uptake components independently of iron 
availability, and hyper-activity of Hog1p led to the activation of a specific response to high 
iron concentrations.  
The effect of the HOG activating antifungal fludioxonil on the expression or activity of cell 
surface high affinity iron uptake proteins of the RIUP was investigated. Fludioxonil repressed 
RIUP components under conditions of iron restriction, during which these components are 
normally induced. Furthermore, fludioxonil decreased the growth of C. albicans during iron 
restriction. Interestingly, the fludioxonil mediated repression of RIUP components appeared 
to be independent of the HOG pathway, as well as of the iron responsive negative regulator of 
iron uptake proteins, Sfu1p. This indicates the existence of a complex regulatory network for 
iron uptake proteins involving Hog1p dependent as well as Hog1p independent components.
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Zusammenfassung  
Ziel dieser Doktorarbeit war die Identifikation von Zelloberflächenproteinen aus dem 
pathogenen Pilz Candida albicans, welche in der Diagnostik dieses Pilzes verwendet werden 
könnten. Weiterhin wurden regulatorische Mechanismen untersucht, welche die Expression 
von solchen Zelloberflächenproteinen, insbesondere Eisenaufnahmeproteinen, kontrollieren.  
Wir haben verschiedene Methoden für die Isolierung von Zelloberflächenproteinen 
angewendet und wählten die ß-(1,3)- Glucosyltransferase Bgl2p als erstes Zielprotein zur 
Diagnose von  C. albicans Infektionen. Auf der Basis von Sequenzhomologien sowie eines 
Modells für die Proteinstruktur von Bgl2p, konnten wir ein für C. albicans Bgl2p spezifisches 
14 Aminosäuren langes Peptid identifizieren. Es wurden monoklonale Antikörper gegen 
dieses Peptid von Projektpartnern hergestellt. Mehrere solcher Antikörper, die aus 
Überständen von Hybridomazelllinien-Kulturen stammten, konnten eine rekombinante, 
aufgereinigte Version des Bgl2p binden. Zwei von diesen Antikörpern konnten auch an ganze 
C. albicans Zellen binden, höchstwahrscheinlich in Abhängigkeit von Bgl2p. Diese 
Antikörper sind somit vielversprechend für die diagnostische Erkennung von C. albicans 
Zellen.  
Es wurden Eisenaufnahmeproteine aus der Gruppe der Multi – Copper – Ferroxidasen durch 
Hitzeextraktion isoliert. Da die Expression dieser Proteine sowohl durch Eisenverfügbarkeit 
als auch durch die Mitogen Aktivierte Protein Kinase Hog1p reguliert war, wurde die Rolle 
von Hog1p in der Antwort von C. albicans auf verschiedenen Eisenkonzentrationen 
untersucht. Es konnte zum ersten Mal bei Pilzen gezeigt werden, dass C. albicans Hog1p an 
der Antwort des Pilzes auf veränderte Eisenkonzentrationen im extrazellulären Milieu 
beteiligt ist. Die basale Hog1p Aktivität reprimiert die Expression von hoch affinen Eisen-
Aufnahme Proteinen unabhängig von der Verfügbarkeit von Eisen, während die Hyper-
Aktivität von Hog1p eine spezifische Antwort auf erhöhte Eisenkonzentrationen aktiviert. Das 
Hog1p-aktivierende Antimykotikum Fludioxonil reprimierte die Expression von  hochaffinen 
Eisenaufnahmeproteinen des reduktiven Wegs selbst unter Eisenmangelbedingungen, unter 
denen diese normalerweise induziert werden. Weiterhin verursachte Fludioxonil leichte 
Wachstumsdefekte von C. albicans unter Eisenmangelbedingungen. Die Fludioxonil 
abhängige Repression von  Eisenaufnahmeproteinen war jedoch weder von Hog1p, noch vom 
negativen Regulator von Eisenaufnahmeproteinen, Sfu1p, abhängig. Dies deutet auf einen 
komplexen Regulationsmechanismus von Eisenaufnahmeproteinen hin, der sowohl Hog1p-
abhängige als auch -unabhängige Komponenten enthält.  
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Chapter 1 Introduction 
1.1 The fungal kingdom 
Fungi constitute a large and diverse group of eukaryotic microorganisms, distinguished by 
successful adaptation to different environmental niches. The total number of fungal species is 
estimated to be 1.5 million of which merely 70000 have been described (Hawksworth & 
Rossman, 1997). Several fungi are of high value for humans. Yeasts of the genus 
Saccharomyces facilitate production of bred, beer and wine since thousands of years, while 
several filamentous fungi are important sources for production of antibiotics (Penicillium 
spp.) or antioxidants (Aspergillus niger). Others are used to protect crops from other 
microorganisms (Trichoderma spp.) and are thus of high importance for the global ecosystem. 
However, in addition to the high nutritional, medical or ecological value of several fungal 
species, other species belonging to this kingdom of eukaryotes have adapted to a parasitic 
lifestyle in plant (Ustilago maydis, Magnaporthe grisea), animal or human hosts (Candida 
spp and others, see below). Therefore, fungal pathogens could threaten human life in addition 
to causing devastating effects to the economy.      
Fungal pathogens of humans evolved diverse lifestyles allowing them to infest different 
niches inside the host. Different host organs and tissues could be affected by fungal 
infections, such as mucocutaneous surfaces (Candida spp.), the respiratory system (A. 
fumigatus, Cryptococcus neoformans, Histoplasma capsulatum), or the skin (Trichophyton 
spp., Blastomyces dermatidiis). Several factors are under consideration to elicit fungal 
infections. The use of immunosuppressive, chemotherapeutic as well as broad spectrum 
antibiotic agents has been proposed to boost the development of fungal infections in addition 
to HIV infection or other causes for immune disorders (Enoch et al, 2006). Indwelling 
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medical devices and implants such as catheters also provide a source for fungal infections, 
especially by Candida spp. (Kojic & Darouiche, 2004).   
The diversity of fungal pathogens and their ability to adapt to different stress conditions, e.g.,  
the acquirement of drug resistance, led to increased frequency of invasive fungal infections 
during the recent years (Pfaller, 2012). Thus, not only new active antifungal agents are 
urgently required, but in addition, a better understanding of fungal adaptation to hostile 
environments is needed.  
The focus of this work is on the human pathogenic fungus Candida albicans, a commensal 
which can cause severe systemic infections, especially in patients with a compromised 
immune system.   
1.2 Candida albicans 
1.2.1 Classification, morphology, genetics and medical relevance 
The genus Candida was first described by Christine Marie Berkhout at the University of 
Utrecht, the Netherlands, in 1923. However, the species C. albicans was isolated earlier by 
C.P. Robin in the 19
th
 century as Odium albicans (Barnett, 2004).  
Candida spp. belong to the phylum of the Ascomycota, or sac fungi, and are classified within 
the family of Saccharomycetaceae along with the baker’s yeast Saccharomyces cerevisiae. 
About 150 Candida spp. are known, but only few of them have medical relevance. The 
Candida clade (Alby & Bennett, 2010; Butler et al, 2009) includes diploid (e.g. C. albicans, 
C. dubliniensis, C. tropicalis, C. parapsilosis and Lodderomyces elongisporus) as well as 
haploid (e.g. C. guilliermondii, C. lusitaniae and Debaromyces hansenii) yeasts (Figure 1.1). 
Not included in this clade is the pathogenic yeast C. glabrata, originally known as Torulopsis 
glabrata, which is haploid and is phylogenetically more related to S. cerevisiae (Dujon et al, 
2004).  
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Figure 1.1 – Phylogeny of the Candida clade and S. cerevisiae.  
Dendrogram acquired from http://www.broadinstitute.org/annotation/genome/candida_group/MultiHome.html. 
C. albicans is characterized by polymorphism. It can grow as a unicellular yeast, as well as 
filamentous pseudo-hyphae or true hyphae (Figure 1.2). Pseudo-hyphae of C. albicans appear 
as elongated cells with constrictions at the septa, while true hyphae lack such structures and 
can be distinguished by their parallel-sided walls (Sudbery et al, 2004). Figure 1.2 shows 
these three morphologies of C. albicans within one culture. In addition to the three 
morphologies mentioned above, C. albicans can form chlamydospores, i.e. spores with thick 
cell walls seen under distinct growth conditions, such as carbon source starvation (Jansons & 
Nickerson, 1970).      
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Figure 1.2 – The three morphological forms of C. albicans.  
Microscopic analysis of SC5314 cells incubated in RPMI medium (+10% FBS) at 37 °C for 5 h. Arrows indicate 
the different morphologies (yeast, pseudo-hyphae and hyphae).   
Eight chromosomes (1 – 7 and R) represent a haploid genome size of ca. 14.9 MBp 
containing up to 6400 open reading frames (ORFs) (Braun et al, 2005; Odds et al, 2004). The 
clinical isolate SC5314 was the first C. albicans strain to be sequenced. 
For a long time, C. albicans was considered to be an imperfect fungus, lacking a complete 
sexual cycle.  However, this yeast has been found to possess a DNA region, called the Mating 
Type Like (MTL) locus, orthologous to the mating type locus (MAT) of S. cerevisiae (Hull & 
Johnson, 1999). Engineered C. albicans cells were able to undergo mating both in vitro and in 
a murine infection model (Hull et al, 2000; Magee & Magee, 2000).  
Additionally, mating competent haploid cells were recently discovered suggesting that C. 
albicans could be no more considered as an obligate diploid (Hickman et al, 2013).  
Mating competent diploids have to be homozygous at the MTL (MTLa/a or MTLα/α locus). 
Such cells have been termed “opaque” because of the appearance of colonies formed by those 
cells on agar plates (Slutsky et al, 1987). Opaque cells are elongated, thus differing 
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morphologically from the “white” colonies, formed by the round to oval yeasts. Mating 
competence could result either from mitotic recombination or from loss of one copy of 
chromosome 5 and duplication of the homologous chromosome (Sasse et al, 2013). White-to-
opaque switch in C. albicans is regulated by the Wor1p transcription factor. In strains which 
are heterozygous at the MTL locus, the a1-α2 factor represses Wor1p expression to basal 
levels, thus locking the cells in the white phase. The repression of Wor1p is relieved in MTL 
homozygous cells, which allows switching to the opaque phase when Wor1p levels are above 
a critical threshold. This phenomenon points to the stochastic nature of the white-to-opaque 
switch regulation (Morschhauser, 2010b).   
Another important genetic feature of C. albicans is the non-standard codon usage, whereby 
CTG encodes serine instead of leucine (Santos & Tuite, 1995). This may complicate 
heterologous expression of C. albicans proteins in other organisms like Escherichia coli.  
C. albicans is an opportunistic pathogen. It colonizes as commensal up to 30 – 70% of healthy 
individuals (Gow et al, 2012). Patients with a compromised immune system are at high risk to 
acquire systemic infections by Candida spp., which constitute the fourth highest cause for 
nosocomial bloodstream infections with a lethality rate of up to 40% (Pfaller & Diekema, 
2007). One of the reasons for the success of C. albicans as a pathogen is its high adaptability 
to various environmental niches, which are characterized by the availability of nutrients and 
essential elements.  
Cell surface proteins are of high importance for pathogens, and have a wide range of 
functions, as enzymes, receptors or transporters. They play a role in adhesion to host tissues, 
cell-cell aggregation, nutrient uptake, efflux of deleterious compounds or remodeling of the 
cell wall (Chaffin, 2008; Hiller et al, 2011; Morschhauser, 2010a; Verstrepen & Klis, 2006). 
By this, cell surface proteins support the adaptation of C. albicans to environmental changes. 
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1.2.2 The C. albicans cell wall 
The cell wall is the outermost boundary of fungal cells. It confers rigidity and protection from 
alterations of chemical and physical parameters in the surrounding milieu. Additionally, cell 
walls of fungal pathogens play a major role in virulence, as adhesion and first interaction of 
pathogenic fungi with host cells are mediated by cell wall components (Ruiz-Herrera et al, 
2006). Basically, the cell wall of C. albicans shows similar molecular organization to that of 
the baker’s yeast Saccharomyces cerevisiae (Gozalbo et al, 2004). Previous studies have 
shown that the C. albicans cell wall is composed of a network of three major polysaccharides. 
Mannans, ß-glucans and chitin, make up 80 to 90 % of the cell wall composition, whereas 
proteins and lipids (e. g. phospholipomannan) present about 5 – 20 % and 1 – 7 % 
respectively (Gozalbo et al, 2004). A schematic structure of the C. albicans cell wall is shown 
in Figure 1.3. 
 
Figure 1.3 – Schematic organization of the C. albicans cell wall.  
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1.2.2.1 Cell wall carbohydrates 
ß-glucans are glucose polymers containing ß-(1,3)- and ß-(1,6) -linkages, while chitin is the 
polymer of N-acetyl-D-glucosamine (GlcNAc) and mannan the polymer of mannose, an 
isomer of glucose. ß-glucans and chitin are prevalently located in the inner layer of the cell 
wall and are responsible for cell wall rigidity. Mannose polymers (linked to mannoproteins) 
cover the cell wall’s outermost layer forming the so called “mannan coat”.  
The human immune system is able to bind C. albicans yeast ß-glucans by means of the 
dectin-1 receptor. Thus, C. albicans shields its cell wall glucan network underneath outer cell 
wall components (e.g. the mannan coat), rendering it hidden and thus inaccessible by 
phagocytes (Gantner et al, 2005).  
Synthesis of ß-(1,3)-glucans is inhibited by echinocandine antifungals such as caspofungin, 
micafungin or anidulafungin (Kofla & Ruhnke, 2011). C. albicans responds to such cell wall 
perturbing agents by inducing the cell wall integrity and cell wall remodeling pathways 
leading to increased cell wall chitin content as well as to induction of the expression of 
proteins involved in glucan branching (Angiolella et al, 2009; Costa-de-Oliveira et al, 2013; 
Roman et al, 2009; Walker et al, 2008). The role of mitogen activated protein (MAP) kinases 
in response to cell wall stresses will be discussed in later parts of this chapter. 
1.2.2.2 Cell wall proteins 
Cell wall proteins (CWPs) are generally divided in two major classes according to the nature 
of their attachment to the C. albicans cell wall: covalently and non-covalently bound CWPs. 
The most abundant covalently bound CWPs are linked to ß-(1,6)-glucan through a 
glycophosphatidylinositol (GPI) anchor remnant (GPI-CWPs). GPI-CWPs are linked to the ß-
(1,6)-glucan polymer by phosphodiester bonds that can be specifically cleaved by HF-
pyridine, thus releasing GPI-CWPs from the cell wall (de Groot et al, 2004). It was suggested, 
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that the GPI anchors might play a role in targeting those proteins to the cell surface (Chaffin, 
2008).    
PIR proteins (Proteins with internal repeats) constitute another class of CWPs which are 
covalently attached to the polysaccharide network. These proteins are linked directly to ß- 
(1,3)-glucan by alkali sensitive linkages and are thus extractable by NaOH treatment (de 
Groot et al, 2004). 
On the other hand, non-covalently bound CWPs lack any covalent attachment to cell wall 
polysaccharides. Such proteins can be removed from cell wall preparations by heat (Klebl & 
Tanner, 1989) or with denaturing agents such as urea or combination of SDS and heat (de 
Groot et al, 2004; Rico et al, 1997). Some of these proteins may be secreted to the external 
milieu or have substrates within the cell wall (Goldman et al, 1995; Hartland et al, 1991; 
Hiller et al, 2007; Sorgo et al, 2010).  
Several proteins with cytosolic functions were reported to be localized on the cell surface of 
C. albicans (Eroles et al, 1997; Gil-Navarro et al, 1997; Urban et al, 2003). Some of these 
proteins have been implicated with binding to host extracellular matrix proteins thus 
indicating a moonlighting activity (Crowe et al, 2003).   
In general, CWPs could be involved in a variety of function such as cell wall assembly and 
remodulation, adhesion to host cells and tissues or potentially acting as modulators of the host 
immune system (Nather & Munro, 2008). Additionally, others are involved in the cell 
response to stress situations, e.g. heat shock (Chaffin et al, 1998; Lopez-Ribot et al, 1996) or 
exposure to antifungal drugs (Angiolella et al, 2002; Angiolella et al, 2009).  
The cell wall proteome of C. albicans is dependent on the morphology. It has been reported 
that hyphal cell walls have a characteristic protein composition (Heilmann et al, 2011). 
Furthermore, it has been suggested that some CWPs could carry a “morphogenetic code”, 
resulting in active modulation of the molecular organization of the cell wall constituents 
11 
 
(Valentin et al, 2000). Other works reported that some cell wall proteins, which are usually 
located in the outer surface of the cell wall in one morphology, are found cryptic following 
dimorphic transition (Ollert & Calderone, 1990).  
Alterations in the cell wall proteome generate cell surface variation, boosting the immune 
evasion strategies of the fungus. Such generation of cell surface variation could possibly be 
accomplished at least through three processes:  
(i)       By transcriptional or post-transcriptional regulation of CWP expression leading 
thus to changes in cell wall proteome composition.  
(ii)       By alteration of characteristic properties of individual proteins.  
(iii) By differential glycosylation of proteins targeted to the cell wall (Nather & Munro, 
2008).  
Thus, expression, regulation, localization and functional analysis of CWPs have been 
subjected to intensive studies for the past years.   
1.2.2.3 Adhesion, aggregation and biofilm formation  
Adhesion of fungal cells is mediated by specialized cell surface proteins, which can bind 
amino acids or sugar residues present on surfaces of other cells (Verstrepen and Klis, 2006). 
Adhesion of C. albicans to host cells and tissues as well as to implants is mediated by several 
cell wall proteins. The Agglutinin Like Sequence (ALS) family of C. albicans includes at 
least eight glycoprotein encoding genes (ALS1 to ALS7 and ALS9) (Hoyer et al, 2008). 
Recently, a new gene was described in the C. albicans WO-1 strain resulting from a 
recombination event between the adjacent ALS1 and ALS5 genes (Zhao et al, 2011). Members 
of the ALS protein family have been implicated in adhesion and biofilm formation (Hiller et 
al, 2011; Hoyer et al, 2008; Murciano et al, 2012), as in iron uptake or cellular aggregation 
(Almeida et al, 2008; Fu et al, 2002; Gregori et al, 2011). Expression of the ALS members 
Als1p and Als5p in S. cerevisiae allowed this non-pathogenic yeast to adhere to human cells 
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and extracellular matrix components as well as to synthetic peptides (Fu et al, 1998; Gaur & 
Klotz, 1997; Klotz et al, 2004). 
Some C. albicans adhesins are restricted to the yeast form, such as Yw1p, while others are 
hyphae specific, such as Als3p or Hwp1p. Transcripts of HWP1 are only found in hyphae but 
never in blastospores, so that this specificity could be used as reporter (Almeida et al, 2008; 
Granger et al, 2005; Heintz-Buschart et al, 2012; Staab et al, 1996; Staab & Sundstrom, 1998; 
Uhl & Johnson, 2001). 
Adhesion of C. albicans cells to each other mediates the formation of large aggregates or 
‘flocs’. Flocculation in yeasts is defined as a non-sexual, homotypic, reversible and 
multivalent aggregation of thousands to millions of yeast cells leading to the formation of 
flocs (Soares, 2011). Due to its importance in brewing industry, flocculation of yeasts has 
been under extensive study during the past century. As flocculation in yeasts is known to be 
induced on response to stress situations (Verstrepen & Klis, 2006), the interest in studying 
this phenomenon in pathogenic yeasts increased. C. albicans is known to flocculate in 
response to various changes in the surrounding milieu, such as nutrient availability or 
exposure to different chemicals (Bianchi, 1964; Cleary et al, 2012; Gregori et al, 2011; Kaba 
et al, 2013; Kamaya, 1969). One of the mechanisms resulting in this form of cellular 
aggregation is the interaction of carbohydrate binding proteins (lectins) of one cell with 
mannans attached to proteins on the other cell. However, knowledge on the molecular level is 
still sparse.   
Biofilms are surface associated populations of microorganisms embedded in a matrix of 
extracellular polymeric substances (Nobile et al, 2009). C. albicans has the ability to form 
biofilms on both biotic (mucosa) as well as abiotic (medical devices such as catheters or 
dental prosthetics) substrates (Mayer et al, 2013). C. albicans biofilms have increased 
resistance to several antifungals including fluconazole, amphotericin B, nystatin and 
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voriconazole (Fanning & Mitchell, 2012). The architecture of Candida mucosal biofilms is 
complex. They include yeast and hyphal morphologies, as well as commensal bacterial 
species and host components (Dongari-Bagtzoglou et al, 2009). 
1.2.3 Iron uptake  
1.2.3.1 Iron availability in the host 
Iron is essential for almost all organisms as it is a co-factor of a variety of proteins involved in 
important cellular processes. Its biological importance is attributed to its ability to undergo 
single electron redox reactions, thus oscillating between the oxidized ferric (Fe
3+
) and the 
reduced ferrous (Fe
2+
) states. However, this redox reactivity itself is a potent source of 
toxicity as ferrous iron leads to the generation of the highly reactive hydroxyl radical (OH
·
) by 
Fenton chemistry (Hentze et al, 2004).  
Iron acquisition by pathogens is a limiting factor for fungal, bacterial and protozoan infections 
(Nairz et al, 2010; Schaible & Kaufmann, 2004; Sutak et al, 2008; Weinberg, 2009). Thus, 
iron accessibility for pathogens is restricted in mammalian hosts by proteins which bind iron 
with high affinity, such as hemoglobin, transferrin and ferritin (Weinberg & Miklossy, 2008). 
This strategy of iron withholding restricts iron accessibility to pathogens in addition to the 
reduction of iron mediated toxicity. However, most pathogens on their turn have developed 
different strategies for iron acquisition to counteract this restricted iron environment inside the 
host.  
The major iron binding protein in human serum is transferrin. This glycoprotein has a high 
Fe
3+
 chelation affinity at physiological pH. Transferrin’s affinity for iron ions decreases with 
increased acidity (Jurado, 1997). Each transferrin molecule has two ferric iron ion binding 
sites (Harris, 2012). Accordingly, serum transferrin can be present as di-ferric transferrin 
(loaded with two Fe
3+
 ions; saturated transferrin), mono-ferric transferrin (loaded with one 
Fe
3+
 ion) or apo-transferrin (iron free). In healthy individuals, ca. 30% of total transferrin 
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molecules are saturated. However, iron overload, due to hereditary hemochromatosis or due to 
repeated blood transfusions in thalassemia and leukemia patients (Hunter et al, 1984; 
Musallam et al, 2012; Siddique & Kowdley, 2012), results in high iron saturation of 
transferrins thus increasing the risk of elevated free iron concentrations.   
Human serum has been known for a long time to inhibit C. albicans growth, mainly through 
the iron chelating activity of apo-transferrin (Caroline et al, 1969; Minn et al, 1997). Such 
effect could be abolished by addition of iron to the growth medium or in sera with high 
saturation of transferrin as found in leukemia patients.  Indeed, C. albicans infections are 
known associated with leukemia or other diseases with iron overload (Bullen et al, 2006; 
Khan et al, 2007). 
In general, iron uptake during infection by C. albicans is considered as virulence factor 
(Almeida et al, 2009). Pretreatment with iron chelators protected endothelial and epithelial 
cells from C. albicans mediated injury, while loading cells with iron reversed this effect 
(Almeida et al, 2008; Fratti et al, 1998). Furthermore, genes of iron acquisition proteins were 
upregulated during C. albicans liver tissue infection (Thewes et al, 2007). On the other hand, 
iron availability was linked to drug resistance as well as to morphology of this fungus 
(Hameed et al, 2008; Prasad et al, 2006). 
1.2.3.2 C. albicans iron uptake systems 
Three systems for iron uptake by C. albicans are known:  
(i) Recently, a heme uptake system allowing the utilization of iron bound to 
hemoglobin was identified, including hemoglobin receptors, e.g. Rbt5p  
(Weissman & Kornitzer, 2004; Weissman et al, 2008).  
(ii)  C. albicans acquires iron from ferrichrome type siderophores via the receptor 
Sit1p (Heymann et al, 2002; Lesuisse et al, 2002). Considering the lack of 
genes required for siderophore biosynthesis in C. albicans, it is believed that 
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this pathway allows the uptake of iron bound to siderophores produced by 
other pathogens or commensals (Almeida et al, 2009).  
(iii) The third pathway is called the reductive pathway, as first ferric iron is reduced 
to ferrous iron by membrane associated ferric reductases (Morrissey et al, 
1996), before being reoxidized by members of the multicopper ferroxidase 
(MCFO) family (Knight et al, 2002).  
MCFOs form together with the iron permease Ftr1p a high affinity iron uptake (HAIU) 
complex in the plasma membrane (Ramanan & Wang, 2000; Ziegler et al, 2011). This 
pathway was shown to be responsible for iron uptake not only from iron salts but also from 
iron loaded host proteins such as transferrin and ferritin (Almeida et al, 2008; Knight et al, 
2005). Loss of FTR1 rendered C. albicans completely avirulent in a mouse model of systemic 
infection and abolished damage of oral epithelial cells (Almeida et al, 2008; Ramanan & 
Wang, 2000). This underlines the importance of this pathway for virulence of C. albicans. 
Figure 1.4 shows a schematic illustration of the C. albicans reductive iron uptake pathway 
(RIUP). 
Whereas reduction of ferric iron to ferrous iron by reductases increases solubility and 
availability of iron, the function of MCFOs leading to the re-oxidation of Fe
2+
 is not as well 
understood. Complex formation with the permease and channeling of Fe
3+
 could maintain the 
availability of iron and deliver iron in the oxidized, i.e. the less reactive and toxic form, to the 
cytosol.  
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Figure 1.4 – Schematic illustration of the C. albicans reductive iron uptake pathway (RIUP).  
C. albicans is able to acquire both free as well as host-protein bound iron (e.g. by ferritin or transferrin; red 
ellipse) by means of this pathway. Iron binding host proteins are bound by their respective receptors (grey 
rectangles). Ferric iron (oxidized, yellow circles) is first reduced (Fe
2+
; white circle) by means of membrane 
associated ferric reductases (vertical grey cylinder), and becomes subsequently re-oxidized by one or more 
multicopper ferroxidase (MCFO) member (blue cylinder). The resulting oxidized iron is channeled by means of 
a ferric permease Ftr1p (horizontal grey cylinder) to intracellular compartments.  
1.2.3.3 Regulation of iron uptake components in C. albicans 
Due to the toxic potential of iron by generating reactive oxygen species (ROS) (Galaris & 
Pantopoulos, 2008), cellular iron homeostasis is subjected to tight regulation. Several 
microorganisms possess transcriptional repressors which are responsible for downregulation 
of iron uptake genes under sufficient iron conditions, such as the bacterial Fur repressor 
(Cornelis et al, 2011; Smaldone et al, 2012). In several fungi, iron uptake genes are mainly 
repressed by GATA family transcription factors which are believed to act as iron sensors 
(Haas, 2012; Haas et al, 1999; Jung et al, 2006; Pelletier et al, 2002; Zhou et al, 1998).  
In C. albicans, the transcriptional regulators Sfu1p, Hap43p and Sef1p constitute what is 
known as the iron responsive regulatory network (IRRN) (Chen et al, 2011) (Figure 1.5). 
Sfu1p is a GATA-type repressor, which is active under high iron conditions and negatively 
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regulates genes encoding for ferric reductases, MCFOs, iron permeases, as well as Hap43p, 
the regulatory element of the CCAAT-binding complex (CBC) (Chen et al, 2011; Lan et al, 
2004). Hap43p is a transcription factor that is activated under low iron conditions and 
represses the expression of Sfu1p and of iron utilization genes so that repression of genes 
involved in iron uptake is relieved and the limited amount of iron is efficiently used for vital 
proteins (Hsu et al, 2011). Sef1p was identified recently as a transcriptional activator of iron 
uptake genes (Homann et al, 2009), and is repressed by Sfu1p, but activated under low iron 
conditions. It induces Hap43p and iron uptake genes, such as FET3 (encoding an MCFO), as 
well as a copper-transporting ATPase encoding gene (CCC2) required for MCFO activity 
(Chen et al. 2011). Very recently, Sfu1p was found to regulate iron uptake by post-
transcriptionally inhibiting Sef1p in addition to its inhibition on transcriptional level (Chen & 
Noble, 2012).    
 
Figure 1.5 – The iron responsive regulatory network of C. albicans.  
C. albicans possesses a network of three transcription factors (Sfu1p, Sef1p and Hap43p), which is responsible 
for adaptation of this fungus to host niches with different iron availability. Under iron repleted conditions, Sfu1p 
negatively regulates Sef1p on both transcriptional and post-transcriptional levels. Under iron depleted 
conditions, Sef1p activates Hap43p expression which negatively regulates Sfu1p as well as iron utilizing 
proteins. Sef1p induces expression of high affinity iron uptake proteins. 
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In addition to the IRRN, other transcription factors, such as Tup1p and Rim101p, are involved 
in regulation of iron uptake genes, but their roles are not as obvious. Tup1p is a global 
repressor which may be recruited to iron responsive genes via interaction with Sfu1p (Lan et 
al, 2004), while regulation by Rim101p is influenced by pH (Bensen et al, 2004). This 
complex regulation of iron uptake probably helps C. albicans to successfully adapt to niches 
with different iron levels (Chen et al, 2011).  
1.2.4. Morphologic switching 
Morphologic switching is a central factor in virulence of C. albicans. While the hyphal 
morphology accounts for invasive growth in host tissues (Sudbery et al, 2004), the yeast form 
is important for dissemination and colonization of the host especially in the early stage of 
infection (Saville et al, 2003; Thompson et al, 2011). Thus, both morphologies contribute to 
the infection process. 
In filamentous fungi, hyphae grow as filaments in a polarized manner with accumulation of 
secretory vesicles at the apical tip, forming an organelle known as the Spitzenkörper 
(Steinberg, 2007). C. albicans possess such an organelle which is only found in hyphal cells 
(Crampin et al, 2005).  
Several parameters are known to induce formation of hyphae. Neutral to basic pH, growth at 
37 °C as well as the presence of serum shift C. albicans morphology towards the hyphal form. 
Remarkably, all of these factors are present in the bloodstream. Furthermore, quorum sensing 
compounds such as homoserinelactone or farnesol repress  hyphae formation while N-acetyl 
glucosamine and nitrogen limitation induce it (Sudbery, 2011).   
1.2.5. Stress activated signaling pathways and stress adaptation in C. albicans 
C. albicans is confronted with different stress situations inside the host. Phagocytes such as 
macrophages induce reactive oxygen (ROS) and nitrogen (RNS) species (Brown et al, 2009). 
Nutrient scantiness inside the host is a further stress factor. Additionally, antifungal drug 
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treatment demands further flexibility in order to survive. In order to adapt successfully to such 
hostile environments, C. albicans possesses a complex network of signaling pathways which 
regulate cellular responses to different stress situations. 
Hog1p encodes the mitogen activated protein kinase (MAPK) orthologous to human p38 
(Cheetham et al, 2011) and to stress – activated protein kinases (SAPK) in other yeasts 
(Enjalbert et al, 2006). In C. albicans, Hog1p responds to at least three environmental 
stresses; namely osmotic, oxidative and cell wall stress (Monge et al, 2006). In response to 
those stresses, Hog1p becomes phosphorylated and translocates to the nucleus (Smith et al, 
2004). hog1 null mutants were found to be hypersensitive to those stress conditions, which 
lead to Hog1p activation, in particular to extracellular oxidizing agents (Alonso-Monge et  al, 
2003; Smith et al, 2004). At least the response to oxidative and osmotic stress depends on the 
mitogen activated protein kinase kinase Pbs2p (Arana et al, 2005). Among the substrates of 
Hog1p is the transcription factor Sko1p (Alonso-Monge et al, 2010) so that the activation of 
Hog1p modulates gene expression profiles (Enjalbert et al, 2006).  
The fungal cell wall is considered as an attractive target for antifungal drug development, as 
this organelle is missing in humans (Gozalbo et al, 2004). As mentioned in 1.2.2.1, 
echinocandine antifungals represent a major class of cell wall targeting drugs. C. albicans 
responds to cell wall stress by means of the cell integrity pathway, with Mkc1p as its final 
MAPK (Ernst & Pla, 2011). The MAPK Cek1p is involved in cell wall biosynthesis and 
responds to caspofungin mediated cell wall damage as does Mkc1p. In this case, the 
activation of Cek1p is dependent on the cell surface sensor mucin Msb2p (Roman et al, 2009).  
1.2.6 Diagnostic approaches for C. albicans and other Candida spp. in infected patients 
Due to the high mortality rate of Candida spp. infections, early identification of Candida spp. 
is very important for successful treatment.  
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The microorganisms can be detected in whole blood, serum, saliva or other body fluids or on 
mucosal surfaces. Approaches based on blood cultivations are time consuming and in many 
cases insensitive as fungemia is thought to occur with only < 10 CFU/ mL of whole blood 
(Pryce et al, 2003). Thus, rapid identification is required especially the case in the early phase 
of infection.  
Several other techniques have been used for diagnosis of C. albicans based on nucleic acid 
(Pryce et al, 2003), protein (Lain et al, 2007) or carbohydrate (Lew et al, 1982; Ostrosky-
Zeichner et al, 2005) detection. Approaches which are based on the detection of anti- C. 
albicans antibodies in serum are not appropriate for immunocompromised patients, since the 
immune response of those individuals is severely restricted.  
Specificity of the applied tests is also critical for correct treatment, since some Candida spp. 
are resistant to antifungals, such as C. glabrata (Fidel et al, 1999). Thus, correct identification 
of the Candida spp. is critical for convenient selection of antimycotic therapy (Kragelund et 
al, 2013). Furthermore, distinguishing infection from colonization would also be of great 
importance for diagnostic approaches. This could be achieved by targeting antigens involved 
in virulence.   
Detection of Candida spp. is thus currently one of the most important fields of microbial 
diagnosis with new tools being permanently described for this purpose (El-Kirat-Chatel et al, 
2013; Neely et al, 2013)  
1.3 Aim of this study 
Within the “Lab in a Hankie1” project, we aimed to identify cell wall proteins which could 
serve as diagnostic markers for C. albicans infections. The main target of this project is to 
specifically recognize viable pathogens, such as C. albicans, by sensor molecules (e.g. 
                                                          
1
 http://www.taschentuchlabor.de/index1a6a.html?id=75 
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antibodies), which recognize the pathogen through proteins present on the pathogen cell’s 
surface. This would help early identification of the pathogen and thus shortens diagnosis time 
and accelerates suitable medical treatment of the infected patient. Suitable target proteins 
should be identified for this aim and antibodies recognizing these proteins should be 
generated and evaluated on recognizing whole C. albicans cells. The desired antibodies 
should be specific for C. albicans and allow differentiation between C. albicans and non-
albicans Candida species.  
The ability of C. albicans to adapt to various stress situations enabled this pathogen to persist 
in hostile environments inside the host. Although iron accessibility by pathogens is restricted 
by healthy hosts, several hematological or genetic diseases have been connected with iron 
disorders; including iron overload. The increase of free iron means this nutrient would be 
more accessible for pathogens; however, iron toxicity constitutes a major stress factor for 
those pathogens. C. albicans infection has been known to be associated with iron overload 
diseases (Caroline et al, 1969) and this fungus has been suggested to grow well during iron 
overload conditions (Minn et al, 1997). However, the mechanisms allowing this fungus to 
adapt to high iron concentrations are still unknown.  Even though transcriptional regulators of 
the iron responsive network were identified, signaling pathways, which govern the activity of 
these regulators, are less well known. Four iron uptake genes, namely the ferric reductase 
FRE10, the hemoglobin receptor RBT5, the high affinity iron permease FTR1 and the MCFO 
FET34, were found to be de-repressed in cells lacking HOG1 under sufficient iron conditions, 
which are usually repressive for these genes (Enjalbert et al, 2006). As mentioned above, 
Hog1p becomes activated by phosphorylation in a Pbs2p (MAPKK) dependent manner. Thus, 
an aim of this thesis was to determine whether the Hog1p MAPK plays a role in the response 
to iron availability.  
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Synergistic use of iron chelators and drugs which repress the expression of C. albicans high 
affinity iron uptake (HAIU) proteins could help fighting C. albicans infections of iron 
overload patients. Repression of HAIU components during iron restricted conditions (created 
by the iron chelators) should prevent C. albicans from full utilization of its HAIU machinery 
and may thus affect its growth. As the antifungal compound fludioxonil is known to activate 
the HOG pathway of C. albicans by targeting the histidine kinase Cos1p upstream of Hog1p 
(Buschart et al, 2012b; Ochiai et al, 2002), we studied whether fludioxonil had any effect on 
the expression or enzymatic activity of iron uptake proteins of the reductive pathway. 
Fludioxonil was further tested on its effect on C. albicans growth under conditions of 
different iron availability.  
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Chapter 2 Materials and Methods 
2.1 Strains, media and culture conditions 
C. albicans strains used in this study are listed in Table 1. DAY286, JJH37, JMR114 JJH31, 
FB63-1 and FB63-3, TF117, TF147 and TF156 were purchased from the Fungal Genetics 
Stock Centre (Kansas, USA) (McCluskey et al, 2010). Strains CNC13, BRD3 and hAHGI 
were kind gifts from Jesús Plá and co-workers (Madrid, Spain) (Arana et al, 2005; San Jose et 
al, 1996). Escherichia coli strains are listed in Table 2. 
Routinely, all C. albicans strains were cultivated overnight (16 - 24 h) from frozen glycerol 
stocks in 20 or 50 ml YPD medium (Sigma-Aldrich Y1375) at 30 °C. Preparation of all 
cultures was performed under sterile conditions (MaxiSafe 2020 or Herasafe clean benches, 
Thermo Scientific). Inoculation loops were sterilized by sufficient glowing by means of 
Fireboy and Fireboy eco (Integra Biosciences) Bunsen burners. Unless otherwise indicated, 
incubation of C. albicans liquid cultures in growth media was performed in Multitron Shakers 
(Infors-HT) at 30 °C or 37 °C and 160 rpm. Growth was followed by measurements of optical 
densities (OD) of cultures at λ = 600 nm (OD600) in transparent 96 well plates by the µQuant 
microtiter plate reader (Biotek, Bad Friedrichshall, Germany) in triplicates (each 180 µl). 
Liquid media used in this study are summarized in Table 3. 
 
24 
 
Table 1 - C. albicans strains used in this work.     
Strain Genotype Reference 
SC5314 (MYA-2876)  Wild type (WT) (Gillum et al, 1984) 
CAF2-1 URA3/ura3::imm434 IRO1/iro1::imm434 (Fonzi & Irwin, 1993) 
DAY286 ura3∆::imm434/ura3∆::imm434, iro1/iro1, 
ARG4::URA3::arg4::hisG/arg4::hisG, his1::hisG 
/his1::hisG 
(Davis et al, 2002) 
JMR114 (Δhog1) ura3∆::imm434/ura3∆::imm434, iro1/iro1,  
arg4::hisG/arg4::hisG,his1::hisG/his1::hisG, 
hog1::ARG4/ hog1::URA3 
(Nobile & Mitchell, 2009) 
CNC13 (Δhog1) ura3∆::imm434/ura3∆::imm434, iro1/iro1,  
his1∆::hisG/his1∆::hisG hog1::hisGURA3- 
hisG/hog1::hisG 
(San Jose et al, 1996) 
JJH31 (Δpbs2) ura3∆::λimm434/ura3∆::λimm434, iro1/iro1, 
arg4::hisG/arg4::hisG,his1::hisG/his1::hisG, 
pbs2::ARG4/ pbs2::URA3 
(Nobile & Mitchell, 2009) 
BRD3 (Δpbs2) ura3∆::imm434/ura3∆::imm434, iro1/iro1, 
his1∆::hisG/his1∆::hisG pbs2∆ : : cat/pbs2∆ :: cat-
URA3-cat 
(Arana et al, 2005) 
hAHGI (Δhog1 + HOG1) CNC13, ACT1p-HOG1-GFP : : leu2/LEU2 (Arana et al, 2005) 
JJH37(Δcos1) ura3∆::λimm434/ura3∆::λimm434, iro1/iro1, 
arg4::hisG/arg4::hisG,his1::hisG/his1::hisG, 
cos1::ARG4/ cos1::URA3 
(Nobile & Mitchell, 2009) 
FB63-1 and FB63-3 
(Δbgl2) 
ura3∆::imm434/ura3∆::imm434, iro1/iro1,  
arg4::hisG/arg4::hisG,his1::hisG/his1::hisG, 
bgl2::ARG4/ bgl2::URA3 
(Nobile & Mitchell, 2009) 
WT-arg arg4Δ/arg4Δ LEU2/leu2Δ HIS1/his1Δ 
URA3/ura3Δ::imm434 IRO1/iro1Δ::imm434 
(Homann et al, 2009) 
TF156 (Δefg1) arg4Δ/arg4Δ LEU2/leu2Δ HIS1/his1Δ efg1Δ/efg1Δ 
URA3/ura3Δ::imm434 IRO1/iro1Δ::imm434 
(Homann et al, 2009) 
TF117 (Δtup1) arg4Δ/arg4Δ LEU2/leu2Δ HIS1/his1Δ tup1Δ/tup1Δ 
URA3/ura3Δ::imm434 IRO1/iro1Δ::imm434 
(Homann et al, 2009) 
TF147 (Δsfu1) arg4Δ/arg4Δ LEU2/leu2Δ HIS1/his1Δ sfu1Δ/sfu1Δ 
URA3/ura3Δ::imm434 IRO1/iro1Δ::imm434 
(Homann et al, 2009) 
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Table 2 - E. coli strains used in this work.     
Strain Genotype Reference 
XL-1 BLUE  recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac 
(Arias et al, 2000) 
Rosetta
TM
 2 (DE3) F
-
ompT hsdSB (rB
-
 mB
-
) gal dcm 
pRARE2 (cam
R
) 
(Machner & Isberg, 
2006) 
Ca_BGL2_FLAG3x_His8x_-SP3 Rosetta
TM
 2 (DE3) + 
Ca_BGL2_FLAG3x_His8x_-SP 
This study 
Ca_BGL2_FLAG3x_His8x_+SP6 Rosetta
TM
 2 (DE3) + 
Ca_BGL2_FLAG3x_His8x 
This study 
 
Table 3 – Liquid growth media used in this work. 
Medium Composition 
RPMI  8.4 g l
-1
 RPMI 1640 (Sigma-Aldrich R1383), 2 g l
-1
 glucose, 0.165 M 3-(N-morpholino) 
propanesulfonic acid (MOPS), adjusted to pH 7.3 with 10 N NaOH 
YNB 6.7 g l
-1
 Yeast Nitrogen Base (Sigma Y1250), 2 g l
-1
 glucose, 0.165 M 3-(N-morpholino) 
propanesulfonic acid (MOPS), adjusted to pH 7.3 with 10 N NaOH 
YPD Sufficient iron medium; 10 g l
-1
 yeast extract, 20 g l
-1
 peptone, 20 g l
-1
 dextrose (Sigma-
Aldrich Y1375) 
RIM Restricted iron medium; YPD + 200 µM bathophenanthroline disulfonate (BPS) (Sigma 
146617) 
TB Terrific Broth; 12 g l
-1
 tryptone, 24 g l
-1
 yeast extract, 0.4 % (v/v) glycerol, 2.31 g l
-1
 
KH2PO4, 12.54 g l
-1
 K2HPO4  
LB Luria-Bertani low salt medium; 10 g l
-1
 tryptone, 5 g l
-1
 yeast extract, 5 g l
-1
 NaCl 
The pH of respective media and buffers was adjusted by a Hanna Instruments pH 211 
microprocessor pH meter (Kehl, Germany). Unless otherwise indicated, cells from overnight 
cultures were diluted to an OD600 ~ 0.2 in YPD medium or restricted iron medium (RIM) 
which was produced by adding 200 µM of the potent iron chelator bathophenanthroline 
disulfonate (BPS) to YPD, and grown until early exponential phase (3 h) at 30 °C (pre-
culture). When overnight cultures growth did not exceed OD600 ~ 0.5, no pre-culture was 
prepared. Cells were harvested from this pre-culture by centrifugation at 4500 x g and room 
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temperature (RT) for 5 min, followed by resuspending in the respective growth medium. 
RPMI1640 is a medium comprising no iron salts; YNB is a defined medium with a basal 
concentration of 1.2 µM Fe
3+
 (information from the suppliers). All liquid media used in this 
study were prepared in ultrapure Milli-Q (MQ) water (Milli-Q Academic A10, Millipore, 
Billerica, USA) and sterilized by filtration using 0.2 µm bottle top filters (Milian) placed on 
top of autoclaved 1 l or 500 ml glass flasks (Schrott) in combination with a KNF Neuberger 
78 (Freiberg) vacuum pump. YPD was also occasionally sterilized by autoclaving at 121 °C 
for 20 min. For autoclaving, HST-4-5-6 (Zirbus, Bad Grund) or BelliMed Infection Control 
autoclaves were used.  
During all experiments, ferric chloride (FeCl3, Sigma-Aldrich) was chosen as ferric iron 
source, while ferrous sulfate (FeSO4, Sigma-Aldrich) served as source for ferrous iron. All 
iron containing stock solutions were freshly prepared immediately before use. For cultivations 
exceeding a cultivation time of 10 min in iron supplemented media, iron stock solutions were 
sterile filtered by 0.2 µm Minisart sterile filters (Sartorius, Göttingen, Germany) before being 
added to the media. Fludioxonil and iprodione were both purchased from Sigma and 5 mg ml
-
1
 stocks of each antifungal were prepared in MeOH. Fetal bovine serum (FBS) was purchased 
from Lonza (charge no. 0SB008) while human plasma was kindly provided by Stefanie 
Ehrentraut and Katja Gremmer (BISA, HZI, Braunschweig). 
Solid media were prepared by adding 12 g l
-1
 of agar (BD Bacto™) to RPMI, YPD, YP-
glycerol (10 g l
-1
 yeast extract (BD Bacto
TM
), 20 g l
-1
 peptone (BD Bacto
TM
), 2% glycerol 
(Merck)) and YP-galactose (10 g l
-1
 yeast extract, 20 g l
-1
 peptone, 20 g l
-1
 galactose (Serva)) 
or 14 g l
-1 
agar to LB and 15 g l
-1 
agar to TB media.  
Glucose was purchased from Fluka, Sorbitol from Sigma and MOPS from J.T.Baker or 
Sigma. 
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Sartorius Excellence, Sartorius Research and Kern&Sohn balances were used for weighing 
chemicals and medium constituents.  
2.2 Protein analysis 
2.2.1 Extraction of cell surface proteins from whole cells 
For the extraction of Bgl2p and MCFOs, an overnight culture was diluted in YPD to an OD600 
~ 0.1 - 0.2 and grown until the early exponential phase (pre-culture). Working cultures were 
prepared by resuspending C. albicans cells from the pre-culture in 20 ml of the respective 
medium at an OD600 ~ 0.3. Cultures were incubated at the respective temperature for 3 – 5 h. 
For overnight cells, overnight cultures were diluted in YPD at an OD600 ~ 0.1 and incubated at 
30 °C for 16 -17 h in 20 or 50 ml YPD. For extraction of Bgl2p at different growth stages, an 
overnight culture was grown in YPD until an OD600 of ca. 0.4 was reached. Cells were diluted 
in 20 ml YPD at an OD600 of ca. 0.1 and grown at 30 °C until an OD600 of ca. 0.4, 1.5 or 3.2 
was reached respectively. For all experiments, cells were harvested by centrifugation (4500 x 
g, 5 min and RT) and washed twice with PBS, pH 7.4 (8.0 g l
-1
 NaCl, 0.2 g l
-1
 KCl, 1.44 g l
-1
 
Na2HPO4 · 2 H2O, 0.24 g l
-1
 KH2PO4). Occasionally, the supernatant was removed and the 
pelleted cells were washed with 1 ml PBS and subjected to a further centrifugation step (4500 
x g, 1 - 5 min, and RT). The supernatant was removed and 30 – 100 µl PBS were added to the 
wet cell pellet. Proteins from resuspended cells were extracted by boiling at 90 °C (Memmert 
incubator) for 10 min. The suspension was centrifuged at 10000 x g and 4 °C for 10 min and 
the supernatant was transferred to a new 1.5 ml Eppendorf tube. This centrifugation step was 
repeated once to remove residual cells. The protein extract (supernatant) was subjected to 
protein determination using bicinchoninic acid (Smith et al, 1985). Briefly, BCA solution A 
(10 g l 
-1 
BCA (Sigma), 17.1 g l
-1
 Na2CO3, 1.9 g l
-1
 Na2Tartrat 2 H2O) was mixed with BCA 
solution B (40 g l
-1 
CuSO4 5 H2O) in a ratio of 50:1 (BCA mix). 195 µl BCA mix was added 
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to 5 µl protein extract (1:1 and 1:2) in 96 well plates in duplicates. Alternatively, undiluted 
protein extract was measured in triplicates. As standard, 5 µl of a 5, 2.5, 1.25, 0.625 or 0.3125 
mg ml
-1 
lysozyme solution (in PBS) was added to 195 µl BCA mix each. Samples were 
incubated at 37 °C and 450 rpm (comfort 5355R Thermomixer, Eppendorf) for 30 min 
followed by absorption measurement at λ = 570 nm.  
Equal protein amounts were applied on gels when comparison was necessary. In distinct 
cases, bovine serum albumin (BSA) was added to each sample at a final concentration of 5 µg 
ml
-1
 as a loading control.   
2.2.2 Extraction of cell wall proteins from disrupted cells 
Cells were disrupted either by grinding in liquid nitrogen with clean mortars and pestles 
(Haldenwanger, Berlin, Germany) or by means of a microdismembrator (Mikro-
Dismembrator U, B. Braun Biotech International, Melsungen, Germany).  
For cell disruption by grinding in liquid nitrogen, cells were inoculated from single colonies 
grown on YPD plates into 20 ml YPD and cultivated overnight at 30 °C. Cells were directly 
harvested for extraction by centrifugation (4500 x g, 5 min, 4 °C). Cells were grinded in 
liquid nitrogen and grinded cell powder equivalent to a volume of 2 ml was mixed with 600 – 
1000 µl 5 mM Tris· HCl pH 7.5 supplemented with protease inhibitors (complete, mini, 
Roche) and 1 mM PMSF. The slurry was centrifuged (at least 10000 x g, 10 min, 4 °C), the 
supernatant was discarded and the washing step with the PMSF and protease inhibitor 
supplemented 5 mM Tris·HCl pH 7.5 was repeated 2 – 3 times. 
For cell disruption by microdismembrator, overnight or exponential cells were diluted to an 
OD600 ~ 0.04 – 0.1 and subsequently cultivated overnight in 50 ml YPD at 30 °C. Cells were 
directly harvested for extraction by centrifugation (4500 x g, 5 min, RT). Cells were dropped 
in a liquid nitrogen pre-cooled plastic vial forming cell pearls and frozen in liquid nitrogen 
and eventually stored at -80 °C until further use. Frozen cells were transferred into a liquid 
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nitrogen pre-cooled Teflon vessel with a wolfram-graphite bead. Cells were disrupted by the 
microdismembrator at 2000 rpm for 1 min followed by a cooling step in liquid nitrogen for 1 
min and a subsequent 1 min second disruption step. After disruption, cell powder was 
resuspended in appropriate volumes of 5 mM or 10 mM Tris·HCl pH 7.5 supplemented with 1 
mM PMSF and protease inhibitor (cOmplete, mini or complete protease inhibitor cocktail) 
from Roche (Mannheim, Germany). The slurry was centrifuged (10000 x g, 10 min, 4 °C) and 
subsequently washed 3 - 5 times with 5 mM or 10 mM Tris·HCl pH 7.5 supplemented with 1 
mM PMSF and protease inhibitor.  
All disrupted cells were washed three times with Butanol·H2O mix (0.7:1) for 15 min on ice 
followed by a washing step with ice cold MQ- H2O. Pellets (cell walls) were occasionally 
saved at -80 °C after disruption or after the different washing steps. 
From this point on, cell walls were differently treated according to each extraction method. 
For heat extraction, cell walls were either resuspended in 5 mM Tris·HCl pH 7.5 with or 
without 2% SDS or alternatively resuspended in 12 M Urea (prepared in water) and boiled at 
90 °C for 10 min. Cell walls were pelleted (at least 10000 x g, 10 min, 4 °C) and the 
supernatant was transferred to a new pre-cooled tube. Occasionally, the last centrifugation 
step was repeated to remove residual cellular remains. The extraction step with 12 M Urea at 
90 °C was repeated one further time and the resulting supernatant pooled with the supernatant 
from the previous step. 
For extraction of cell wall proteins by enzymatic digestion of cell wall carbohydrates, cell 
walls were resuspended in 50 mM Tris·HCl pH 6.8 containing 20 U ml-1 Zymolyase 
(Seikagaku BC, Tokyo, Japan), 1 mM PMSF and 1x protease inhibitor (Roche). Incubation 
followed at 37 °C and 160 rpm (Multitron Shaker, Infors-HT) for 2 h. Suspension was 
centrifuged (10000 x g, 10 min, 4 °C) and the supernatants were collected in pre-cooled 
Falcon- or Eppendorf tubes.  
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Extracts deriving from 5 mM Tris·HCl pH 7.5 (without SDS), 12 M Urea and Zymolyase 
were concentrated with appropriate Vivaspin columns of 3 - 10 kDa MWCo. Protein 
determination was performed as mentioned above. 
Proteins were extracted from CAF2-1 or DAY286. Equally treated extracts from Δbgl2 
(FB63-1 or FB63-3) served as negative controls for rapid Bgl2p identification from DAY286. 
Presence of Bgl2p from DAY286 or CAF2-1 derived extracts was confirmed by MS or 
MS/MS analysis.  
2.2.3 SDS-PAGE 
All protein samples were mixed with 5x protein sample buffer (1.5 g sodium dodecyl sulphate 
(SDS), 1.116 g dithiothreitol, 0.015 g bromphenol blue, 7.5 ml 0.5 M Tris·HCl pH 6.8, 7.5 ml 
glycerol) in a ratio of 4:1, boiled at 95 °C for 10 min, shortly centrifuged (up to 10 sec) and 
stored at -20 °C until use. Before loading on SDS-gels, frozen samples were shortly boiled 
again (5 min) at 95 °C and shortly centrifuged (up to 10 sec). Proteins were separated on 
11%T, 2.6%C 1 D SDS-running gels. SDS-gels were prepared as the following: 
Stacking gel (5%): 1.45 ml MQ-H2O 
    625 µl 0.5M Tris, pH 6.8 
   12.5 µl 20% SDS 
   12.5 µl 10% ammonium persulphate (APS) 
     3.5 µl N,N,N',N'-Tetramethylethylendiamin (TEMED) 
    425 µl polyacrylamide (Rotiphorese
®
 Gel 30 (37.5:1), Roth, Karlsruhe) 
Running gel:  1.95 ml MQ-H2O 
   2.50 ml 1.5M Tris, pH 8.8 
   30.5 µl 20% SDS 
   30.5 µl 10% APS  
     4.9 µl TEMED 
   2.50 ml polyacrylamide (Rotiphorese
®
 Gel 30 (37.5:1))  
In some cases, the stacking gel total polyacrylamide concentration was 4 %. Running gels (5 
ml) were poured in fixed glass cassettes (Biometra, Jena, Germany) and the stacking gel was 
directly poured on the running gel until the top of the glass cassettes. Alternatively, a small 
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layer of isopropanol was added on top of the running gel. After polymerization of the running 
gel, the isopropanol layer was removed and the stacking gel was poured on top of the running 
gel. Occasionally, polymerized gels were stored at 4 °C. 
Polymerized gels were fixed  in gel electrophoresis apparatus (Minigel-Twin, Biometra) 
which was filled with running buffer (25 mM Tris, 0.192 mM glycine, 0.1 (v/v) SDS, pH 8.3). 
Gels were as indicated for each experiment using Power Pac 200, Power Pac 300 or Power 
Pac 1000 (Bio-Rad, München, Germany). Gels were subsequently stained with coomassie 
staining solution (0.25% Coomassie-G25, 50% H2O, 42% Ethanol, 8% acetic acid) at RT for 
0.5 - 2 h followed by destaining with distilled water (dH2O) overnight with an occasional 
interval in destaining solution (50% H2O, 42% Ethanol, 8% acetic acid) for 15 - 30 minutes. 
Coomassie staining was extended overnight if required. Occasionally, gels were incubated in 
destaining solution before coomassie staining. Documentation of all gels was performed with 
the GS-800 gel scanner (Bio-Rad) using the Quantity One 1-D analysis software (Biorad), 
except for the gel shown in Supplemental data 2D which was covered with a transparent 
envelope and scanned with Konica Minolta bizhub C353. 
2.2.4 Mass spectrometric and N-terminal sequencing analysis 
For matrix assisted laser desorption ionization-time of flight (MALDI-TOF) peptide mass 
fingerprinting, protein bands were cut out from 1D SDS-gels, washed 3 – 5 times with MQ-
H2O and sent to the proteomic facility for further analysis. Mass spectrometric analysis was 
performed by Dr. Manfred Nimtz and Anja Meier (CPRO, HZI, Braunschweig). Briefly, 
proteins were reduced and carboxamidomethylated, and then subjected to in-gel tryptic 
digestion. The resulting peptides were extracted, desalted using ZipTip devices (Millipore, 
Bedford, USA) and analyzed by MALDI-TOF-MS using a Bruker Ultraflex time-of-flight 
mass spectrometer (Bruker Daltonics, Bremen, Germany). Laser induced dissociation of 
selected peptides for sequence confirmation was performed on the same instrument. 
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Identification of proteins was performed with the mascot search engine at 
http://www.matrixscience.com/. Manual comparison with peptide mass fingerprints of known 
proteins was performed via http://web.expasy.org/peptide_mass/.  
For N-terminal sequencing, proteins were blotted on polyvinylidene fluoride (PVDF) 
membranes (Immunoblot PVDF Membran, Bio-Rad) and stained with Coomassie G-25 at 
room temperature for 5 min. Background color was removed by incubation in destaining 
solution for 30 min. Bands of interest were cut off from the membrane and were subjected to 
N-terminal sequencing using a 494A HT Protein Sequencer (Applied Biosystems) (Edman & 
Begg, 1967). Protein sequencing was performed by Beate Jaschok-Kentner (MOSB, HZI, 
Braunschweig).  
2.2.5 Western blots 
To investigate Hog1p phosphorylation, an overnight culture grown was diluted to an OD600 ~ 
0.2 in YPD and grown at 30 °C for another 3 h. Then cells were resuspended in 20 ml of the 
respective medium at an OD600 ~ 0.3 or 0.1 and were incubated with or without addition of 
FeCl3 at 30 °C for the given time points. Occasionally, cells were washed with the same 
medium before adding iron. As positive control for Hog1p phosphorylation, cells were 
incubated with 1 M of the osmotic stress inducer sorbitol in RPMI at 30 °C for 15 min. 
Protein preparation and western blotting were performed as previously described (Buschart et 
al, 2012b) with some modifications. Briefly, cells were frozen in liquid nitrogen and disrupted 
with the Microdismembrator (see 2.2.2) and the resulting cell powder was resuspended in 
extraction buffer (10 mM sodium phosphate buffer, pH 8.5 containing 5 mM NaCl, 5 mM 
KCl, 11 g l
-1
 glucose, supplemented with 1x protease inhibitor (cOmplete, mini or cOmplete, 
mini EDTA free) and 1 - 2x phosphatase inhibitor (PhosSTOP, Roche)). Protein content of 
each sample was determined as described above. Protein samples were separated by SDS-
PAGE as indicated above (11%T, 2.5%C). Gels were run at 80 V for 30 min and subsequently 
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at 120 V for 90 min. After SDS-PAGE, gels were soaked in blotting buffer (25 mM Tris, 192 
mM glycine, 0,0375% (v/v) SDS) for 30 min at RT. PVDF membranes were shortly soaked in 
MeOH and then in blotting buffer. Proteins were transferred to the PVDF membranes (30 
min, 15 V) using Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell (Biorad) and Power 
Pac 1000 (Bio-Rad). After blotting, membranes were washed for 5 min with TBS-T (20 mM 
Tris HCl, 140 mM NaCl, 0.1% (v/v) Tween-20, pH 7.4) at RT. The membrane was incubated 
with 5% (w/v) nonfat dried milkpowder (Euroclone, Italy) to block unspecific binding of the 
used antibodies to the membrane. Blots were probed at 4 °C overnight with anti-phospho p38 
MAPK (Thr180/Tyr 182) 3D7 rabbit mAB (Cell Signaling Technology) (1:1000) and with 
horse-radish-peroxidase (HRP)-linked anti-rabbit IgG antibody #S7074 (Cell Signaling 
Technology) (1:3000) (1 h at RT) to detect phosphorylated Hog1p. After each incubation step, 
membranes were washed for 4 x 10 min with TBS-T at RT. For detection of total Hog1p, 
membranes were stripped with Re-Blot stripping buffer (Millipore) for 15 min at RT, washed 
for 2 x 10 min with TBS-T and re-blocked with 5% (w/v) nonfat dried milkpowder as 
indicated above. Membranes were probed at RT for 1 h with anti-Hog1p (y-215) sc 9079 
rabbit polyclonal IgG (Santa Cruz Biotechnology) (1:2000) and the HRP-linked anti-rabbit 
antibody mentioned above to detect total Hog1p content. Visualization of protein bands was 
performed as indicated below. 
For detection of recombinant Bgl2p (rBgl2p-SP) by western blot, blotting, blocking and 
washing were performed as mentioned above. Membranes were probed at RT for 1 h with 
HRP-linked Monoclonal ANTI-FLAG
®
 M2 antibody (Sigma) (1:50000). This antibody will 
be referred to as anti-FLAG for simplification.  
All incubation and washing steps were performed with gentle swaying on Heidolph Doumax 
1030, Rockomat (TECNO MARA) or WS5 (Edmund Bühler). All protein bands were 
visualized by chemiluminescence using the ECL Advance Western Blotting Detection Kit 
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(GE Healthcare) or the ECL Prime Western Blotting Detection Kit (GE Healthcare) in a LAS-
3000 (CCD camera, Fujifilm). All antibody working solutions contained 5% (w/v) BSA.  
2.2.6 Dot blots 
For Dot blot analysis, purified rBgl2p was dropped on pre-wetted PVDF membranes and the 
membranes were allowed to dry. Blocking, washing, stripping and protein visualization were 
performed as mentioned in 2.2.5 except for that the Tween-20 concentration of TBS-T was 
reduced to 0.05% (v/v). Membranes were treated at 4 °C overnight with different anti-Bgl2-
a7/8 or anti-Bgl2-a10 containing supernatants and with HRP-linked anti-mouse IgG antibody 
#S7076 (Cell Signaling Technology) (1:3000) containing 5% (w/v) BSA. Some membranes 
were stripped and re-blocked before being subsequently probed with anti-FLAG at RT for 1 h. 
2.3 Expression and purification of recombinant Bgl2p 
2.3.1 Design and synthesis of Ca_BGL2_FLAG3x_His8x 
Design of this gene (Ca_BGL2_FLAG3x_His8x) sequence was performed by Prof. Dr. Peter 
Müller (RDIF, HZI, Braunschweig). The resulting Ca_BGL2_FLAG3x_His8x sequence was 
synthesized by GENEART AG (Regensburg, Germany). See Supplemental data 1 for the full 
sequence of Ca_BGL2_ FLAG3x_His8x.  
2.3.2 Cloning of Ca_BGL2_FLAG3x_His8x 
Upon delivery, Ca_BGL2_FLAG3x_His8x was cloned in the pMK-RQ vector. For 
amplification the delivered vector was transformed in E. coli XL-1 BLUE by electroporation 
(for procedure, see 2.3.3). Transformants were selected on kanamycin (Kan, 30 µg mL
-1
) 
supplemented solid media. Plasmids (minipreps) were isolated with the NucleoSpin® Plasmid 
(Machery-Nagel, Düren, Germany) from 2 mL cultures according to the manufacturer’s 
instructions (2 x 25 µl TE buffer were used in the elution step). Correct 
Ca_BGL2_FLAG3x_His8x size was confirmed by double digestion with NdeI (20000 U ml
-1
, 
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New England Biolabs, Ipswich, USA) and EcoRI (20000 U ml
-1
, New England Biolabs), or 
NcoI (10000 U ml
-1
, New England Biolabs) and EcoRI. Digestions were performed as 
following (digestion protocol 1): 
x µl   DNA (1 µg) 
2 µl   10x NEB4 (New England Biolabs) 
0.25 µl  Enzyme 1 
0.25 µl  Enzyme 2 
(17.5 – x) µl nuclease free water (Promega) 
Incubation was performed at 37 °C for 2 h, followed by inactivation at 65 °C for 17 min and 
subsequent running on ethidium bromide (EtBr) containing 0.8% agarose gels.  
Positive clones were cultivated in 100 mL LB + Kan and plasmids were isolated in large scale 
(midipreps) with PureYield™ Plasmid Midiprep (Promega, Fichtburg, USA) according the 
manufacturer’s instructions. Plasmids were digested either with NdeI/ EcoRI for rBgl2p or 
NcoI/ EcoRI for the rBgl2p version lacking the signal peptide (rBgl2p-SP). pET28c (Merck 
Milipore, Darmstadt, Germany), kindly provided by Dr. Joop van den Heuvel, RPEX, HZI, 
Braunschweig) was digested with the same enzyme combination respectively. Digestions 
were performed as the following (digestion protocol 2): 
x µl  DNA (5 µg) 
4 µl  10x NEB4 (New England Biolabs) 
2 µl Enzyme 1 
2 µl Enzyme 2 
(37.5 – x) µl with nuclease free water (Promega) 
Incubation was performed at 37 °C for 4 h. Insert and linearized vector were run on EtBr 
containing 0.8% agarose gels. DNA bands were visualized in a (Kodak Gel logic 212 Imaging 
System), excised and extracted with NucleoSpin® Extract II (Machery-Nagel) according the 
manufacturer’s instructions (final elution step prolonged to 2 min). Ligase reaction of insert 
and vector was performed as the following for each version: 
Ligation mix for rBgl2p-SP: 
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4 µl  Insert DNA encoding rBgl2p-SP (133 ng)  
4 µl  pET28c (ca. 60 ng) 
2 µl 10x T4 DNA Ligase buffer (Roche) 
1 µl T4 DNA Ligase (Roche, 1 U µl
-1
) 
9 µl  nuclease free water (Promega) 
Incubation was performed overnight at 16 °C (Biometra TPersonal).  
Ligation mix for rBgl2p: 
9 µl  Insert DNA encoding rBgl2p (189 ng)  
4 µl  pET28c (ca. 60 ng) 
2 µl 10x T4 DNA Ligase buffer (Roche) 
1 µl T4 DNA Ligase (Roche, 1 U µl
-1
) 
4 µl  nuclease free water (Promega) 
Incubation was performed 1 h 40 min at 23 °C (Eppendorf Thermomixer Compact) and 
subsequently overnight at 16 °C (Biometra TPersonal). 
Each ligation mix was transformed into E. coli XL-1 BLUE (see below). Positive clones were 
selected on LB + Kan plates and several transformants were inoculated into 2 ml LB + Kan 
medium. Plasmids were purified (minipreps) as indicated above. Purified plasmids were 
digested with the respective restriction enzyme combination (NdeI/ EcoRI for rBgl2p or NcoI/ 
EcoRI for the rBgl2p-SP) according to digestion protocol 1. Clones showing correct size of 
digested DNA fragments were cultivated in large scale (200 ml LB + Kan) and plasmids were 
purified by midipreps. Correct sequence was confirmed by sequencing (performed by 
Stephanie Thies and Tschong-Hun Im, GMAK, HZI) using T7 rev (5’ 
CTAGTTATTGCTCAGCGGT 3’) and T7 fw (5’ TAATACGACTCACTATAGGG 3’) 
sequencing primers [10 pM] (both provided by Dr. Joop van den Heuvel). DNA sequence 
analysis was performed with FinchTV program. Plasmids were then transformed into the 
expression strain, E. coli Rosetta
TM
 2 (DE3) (see below). 
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2.3.3 E. coli transformation 
All E. coli transformations were performed by electroporation. Recipient strains were either 
E. coli Rosetta
TM
 2 (DE3) or E. coli XL-1 BLUE. Electrocompetent cells were generously 
provided by Dr. Joop van den Heuvel. Briefly, 60 µl electrocompetent cells were thawed up 
on ice and added to the ligation mix from 2.3.2 or plasmid DNA (1 – 2 ng). The mixture was 
pipetted into a cold cuvette (0.2 cm) and incubated for 1 min on ice. Cells were pulsed at 25 
µF and 2.5 kV (Bio-Rad Gene Pulser). 1 ml of LB medium was added to the cells followed by 
incubation at 37 °C for 30 min and 225 rpm (Eppendorf Thermomixer Compact). Cells were 
plated on solid medium (LB or TB) supplemented with Kan and chloramphenicol (Cam, 34 
µg ml
-1
) for pET28c variants transformation in E. coli Rosetta
TM
 2 (DE3) or only Kan for 
pET28c variants or pMK-RQ transformation in E. coli XL-BLUE1. As controls E. coli 
Rosetta
TM
 2 (DE3) was transformed with pET42a (selected on Kan supplemented plates) or E. 
coli XL-BLUE1 was transformed with pUC19 (selected on 100 µg ml
-1
 ampicillin 
supplemented plates). Transformants were grown overnight in a 37 °C incubator (Heraeus 
Function line). Several transformants were cultivated in the respective medium followed by 
plasmid preparation. The resulting E. coli Rosetta
TM
 2 (DE3) strains carrying either genetic 
version were subsequently dubbed as Ca_BGL2_FLAG3x_His8x_+SP6 (for rBgl2p) and 
Ca_BGL2_FLAG3x_His8x_-SP3 (for rBgl2p-SP), where the numbers at the end represent the 
selected clone respectively. 
2.3.4 Expression of rBgl2p-SP under non-denaturing conditions 
Ca_BGL2_FLAG3x_His8x_-SP3 was inoculated from frozen glycerol stock in 20 ml of TB + 
Kan + Cam and cultivated at 37 °C overnight (up to 19 h). Cells were diluted 1:20 in the same 
medium (20 – 200 ml) and cultivated for 5 h at 37 °C and subsequently for up to 19 h at 30 
°C. 
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Cultures were divided in 15 or 50 mL falcon tubes and cells were harvested by centrifugation 
for 1 min at 15000 x g. Pellet was resuspended in 300 µl Lysis buffer (4 mL BugBuster® 
Protein Extraction Reagent (Merck Millipore), 0.2 mg ml
-1
 lysozyme and 4 µL 
Benzonase® 2.5 kU (Merck Millipore)) for each 10 ml culture. Slurry was transferred to 
clean 2 ml Eppendorf tubes and shaken at RT and 350 rpm (comfort 5355R Thermomixer, 
Eppendorf) for 20 min. Samples were centrifuged (13000 x g, 20 min and 4 °C). Supernatants 
were pooled (lysate) and expression of rBgl2p-SP was confirmed by SDS-PAGE and 
subsequent western blotting using an anti-FLAG antibody (see 2.2.5). For rBgl2p-SP 
purification, the lysate was concentrated in a Vivaspin6 column, 3 kDa MWCo (Sartorius, 
Göttingen, Germany) to ca. 1 - 2 ml.  
2.3.5 Purification of rBgl2p-SP under non-denaturing conditions 
For rBgl2p-SP purification, 2.5 ml 50% Protino® Ni-NTA Agarose beads (beads) from 
Machery-Nagel were pipetted on top of a PD-10 column (GE Healthcare, Braunschweig, 
Germany) and washed with a total of 25 ml NP-10 buffer (50 mM NaH2PO4, 300 mM NaCl, 
10 mM imidazole, pH 8.0). E. coli lysate containing rBgl2-SP was concentrated to ca. 1 – 2 
ml (see above) and mixed with the beads for 2 min followed by 20 x 1 ml washing steps with 
NP-60 buffer (50 mM NaH2PO4, 300 mM NaCl, 60 mM imidazole, pH 8.0). rBgl2p-SP was 
eluted with a total of 7.8 ml NP-500 buffer (50 mM NaH2PO4, 300 mM NaCl, 500 mM 
imidazole, pH 8.0) and collected in a Vivaspin6 column, 3 kDa MWCo on ice. Eluate was 
concentrated up to 1.5 ml, before being aliquoted, frozen in liquid nitrogen and stored at -20 
°C. Purification of rBgl2p was controlled by SDS-PAGE and subsequent coomassie staining 
as well as by western blotting (see 2.2.5). 
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2.4 Flocculation and sedimentation assays 
Unless otherwise indicated, C. albicans cells from an overnight culture were diluted in YPD 
to an OD600 of 0.2 and grown to the early logarithmic phase. Cells were pelleted (4500 x g, 5 
min and RT) and resuspended in 2 ml of the respective medium containing different iron 
concentrations in 14 ml polypropylene (PP) round bottom falcon tubes (BD sciences, USA) at 
an OD600 of 0.1. Flocculation was observed microscopically after incubation of cells at 30 °C 
for up to 2 h. Alternatively, 20 ml cultures were prepared in 100 ml shaking flasks. 
Flocculation was quantified by determining sedimentation rates of cells based on the protocol 
given in previous reports (Gregori et al, 2011). Briefly, 1 ml of the cell suspension was 
transferred to a plastic cuvette (Plastibrand®, Brand, Wertheim, Germany) after incubation at 
30 °C for 2 h. OD600 (UV1, Spectronic Unicam) was determined directly after vortexing the 
cell suspension (OD1) and after additional 15 min without vortexing (OD2). The R-value was 
calculated as percentage of OD2 relatively to OD1 (OD2/OD1 * 100) and reflects a decrease 
in OD with increased sedimentation rate. Each experiment contained three independent 
replicates, and the mean of the three obtained R-values was taken as a final result.  
2.5 Intracellular ROS determination 
C. albicans cells from an overnight culture were diluted in YPD to an OD600 of 0.2 and grown 
to the early logarithmic phase. Cells were pelleted (4500 x g, 5min and RT), washed once 
with RPMI and resuspended in 2 ml RPMI with or without iron in round bottom falcon tubes 
at an OD600 of 0.1. Cells were incubated at 30 °C for 10 min and immediately pelleted and 
washed twice with MQ-H2O. Cells from all samples were resuspended each in 1.2 ml water 
and each sample was split in two 600 µl samples containing either 70 µM CM-H2DCFDA 
(Invitrogen) or the same volume of DMSO. From those stocks, 3 x 180 µl were pipetted into 
the wells of a 96 well plate (CytoOne, Starlab), leaving empty columns between different 
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samples and incubated in the dark at 30 °C for 30 min (Alonso-Monge et al, 2009). 
Fluorescence intensity was quantified by measuring relative fluorescence intensities (RFUs) 
using the Synergy 4 fluorescence microtiter plate reader (BioTek Instruments GmbH) at an 
excitation wavelength of 485 nm and an emission wavelength of 528 nm. ROS accumulation 
was calculated with respect to background fluorescence of the sample: ROS accumulation = 
(RFU-H2DCFDA / RFU-DMSO). To reverse ROS accumulation, the radical scavenger N-
acetyl cysteine (Sigma-Aldrich) was used at 10 mM final concentration together with iron.  
2.6 Determination of iron levels in growth media and culture supernatants 
Determination of ferric iron concentration in media and culture supernatants was performed 
indirectly by reducing total ferric iron to ferrous iron by ascorbic acid at low pH and 
measuring ferrous iron content through the chromogenic iron chelator bathophenanthroline 
disulfonate (BPS). Briefly, C. albicans cells were prepared as described in the flocculation 
part. Cells were incubated in 2 ml RPMI (OD600 ~ 0.1) containing 30 µM FeCl3 at 30 °C for 
15 min. After incubation, cells were removed by centrifugation (4500 x g, 5 min and RT), and 
880 µl from the supernatants were mixed with 100 µl of 10 mM ascorbic acid and 20 µl of 50 
mM BPS. A medium sample lacking iron was used as negative control, while medium 
supplemented with 30 µM FeCl3 without cells represented the starting conditions and was 
equally treated. All samples were acidified by addition of 10 µl 32% HCl and 180 µl of this 
mixture were pipetted in a transparent 96 well plate and the absorption of the BPS·Fe
2+
 
complex was measured in triplicates at λ = 535 nm (Nilsson et al, 2002; Tamarit et al, 2006) 
immediately after acidification. Absorption of the iron free sample was used to correct 
absorption of all other samples. For each strain, three samples were measured simultaneously, 
each obtained from an independent culture. The whole experiment was repeated three times. 
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2.7 Determination of cell surface ferric reductase activity 
Unless otherwise indicated, C. albicans overnight cultures were diluted in 20 ml of the 
respective medium to an OD600 of 0.2. Antifungal compound, iron or solvent controls were 
added at the respective concentration to the medium. All cultures were incubated at 30 °C for 
3 h. After this growth period, the ferric reductase assay was performed according to (Jeeves et 
al, 2011) with minor modifications. Briefly, early exponential cells were washed once with 
MQ-H2O (4500 x g, 5 min, RT), resuspended in assay buffer (50 mM sodium citrate, 5% 
glucose, pH 6.5) and shaken in round bottom falcon tubes at 30 °C for 15 min. FeCl3 and BPS 
were then added at a final concentration of 1 mM each, to give a final volume of 2 ml at an 
OD600 of 0.1. Cells were incubated at 30 °C for additional 5 min, pelleted (8000 x g, 3 min, 
RT) and the OD520 (λ = 520 nm) of the supernatant was determined (3 x 180 µl). For SC5314 
and DAY286 strains incubated with 30 µM FeCl3 in RPMI medium, no OD600 could be 
determined since those strains formed flocs. In this case, same volumes were taken as for the 
H2O control culture. 
2.8 Viability test 
Viability of cells was measured using the alamarBlue
®
 assay (Invitrogen), which indicates 
particularly the metabolic activity of a culture. C. albicans cells were prepared as described in 
the flocculation part and resuspended in 2 ml RPMI with addition of 30 µM FeCl3 or MQ-
water at an OD600 of 0.1. Cells were incubated at 30 °C for 60 min and immediately pelleted 
and washed once with MQ-H2O. They were resuspended in 2 ml MQ-H2O and 3 x 162 µl 
from each sample was added to 3 x 18 µl alamarBlue
®
 which were previously pipetted in 
three wells of a 96 well plate (CytoOne, Starlab) leaving empty columns between different 
samples. The fluorescence intensity was quantified (t = 0) with the Synergy 4 fluorescence 
microtiter plate reader (BioTek Instruments GmbH) at an excitation wavelength of 540 nm 
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and an emission wavelength of 590 nm. The reagent was incubated at 30 °C for 30 min and 
the fluorescence intensity was quantified again (t = 30 min). The difference to the values 
obtained at t = 0 was taken as indicator of the viability of the cells and the relative metabolic 
activity was calculated according to: Relative metabolic activity (%) = 100 x (RFUiron / 
RFUMQ-water). The experiment was performed three times (n = 3) in total and means of the 
three experiments were taken as final result. 
2.9 Flow cytometric analysis 
Flow cytometric analysis by fluorescence activated cell sorting (FACS) of viable C. albicans 
was based on binding of mouse hybridoma cell culture supernatants containing monoclonal 
anti-a10 antibody (primary antibody) to C. albicans cells, followed by binding of Alexa fluor 
488 anti-mouse IgG antibody (Invitrogen) (secondary antibody) to the primary antibody and 
subsequent analysis in a BD FACSCanto (BD, Franklin Lakes, USA) using the FACSDiva 
6.0 software. C25HD4H4 and C25HD4H8 were concentrated in a Vivaspin500 column 
(MWCo 50 kDa) and resuspended in PSB to give a final concentration of 2.3 fold of the 
original unknown concentration. Briefly, C. albicans stationary phase cells (SC5314 OD600 ~ 
4.0; DAY286 OD600 ~ 4.6; Δbgl2 OD600 ~ 5.4) were resuspended in 500 µl PBS at an OD600 
of 0.01 and pelleted (8000 x g, 3 min, RT). Cells were incubated with 200 µl (OD600 = 0.025) 
of each concentrated hybridoma cell culture supernatant at RT (Thermomixer 5437, shaking 
level 8, Eppendorf) for 30 min followed by three times washing with 500 µl PBS (8000 x g, 3 
min, RT). Cells were incubated with 200 µl of 10 µg ml
-1
 Alexa fluor 488 anti-mouse IgG 
(Invitrogen) on ice for 15 min with swaying (30 rpm, Heidolph Doumax 1030) followed by 
three times washing with 500 µl PBS (8000 x g, 3 min, RT). For negative controls, primary 
antibody was substituted by the same volume of PBS or only PBS (unstained cells) was used 
during all incubation steps respectively.  
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For biotinylation of cell surface proteins, overnight SC5314 cells were resuspended in 500 µl 
PBS at an OD600 of 0.01 and pelleted (8000 x g, 3 min, RT). Cells were incubated with 200 µl 
(OD600 = 0.025) of a 1 mg ml
-1
 EZ-Link Sulfo-NHS-LC-LC-Biotin (Pierce) in PBS pH 8.0 at 
RT (Thermomixer 5437, shaking level 8, Eppendorf) for 30 min followed by three times 
washing with 200 µl PBS pH 8.0 + 100 mM Glycine (8000 x g, 3 min, RT). Cells which were 
not biotinylated were incubated instead with 200 µl PBS pH 8.0. Biotinylated as well as not-
biotinylated cells were incubated with 200 µl of 0.025 mg ml
-1
 FITC labeled Streptavidin (BD 
Pharmingen™) at RT (Thermomixer 5437, shaking level 8, Eppendorf) for 15 min followed 
by three times washing with 500 µl PBS.  
Finally, all cell samples were resuspended in 500 µl PBS in FACS tubes (Sarstedt) before 
being analyzed by flow cytometry. Results are shown for 10
4 
events.    
2.10 Growth tests on agar plates 
For growth tests on solid medium containing fludioxonil or MeOH, C. albicans SC5314 cells 
were pre-cultivated either in YPD or in YPD + 400 µM BPS at 30 °C for 7 h. Cell were 
resuspended in PBS (OD600 = 0.01) and dilutions ranging from 1:1 to 1:10
5
 were dropped (3 
µl each) on agar plates (30 ml) containing the respective combination of medium and 
supplements. Plates were incubated at 30 °C for 16 h. Each growth test was performed on two 
separate plates of the same medium combination.  
For growth tests on RPMI plates, cells of different strains were grown overnight at 30 °C for 
ca. 19.5 h (for SC5314, cells were diluted to an OD600 of 0.1 after 15.5 h and incubated for 
further 4 h). Cells were diluted to ca. 0.5 *10
6 
cells ml
-1
 and 5 µl of each strain were dropped 
on RPMI (30 ml) with or without the given Fe
3+ 
concentration. Serial dilutions were prepared 
(up to 1:10
5
) and 5 µl were dropped on the plates. Incubation followed at 30 °C for 2 days. 
Each growth test was performed on three separate plates of the same medium combination.  
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Agar plates were prepared by mixing 500 ml filter sterilized 2x concentrated respective 
medium with 500 ml of pre-autoclaved liquid 2x Bacto
TM
-agar (24 g l
-1
).  
A Brother Hi-Speed microwave machine was used for liquidation of sterile solid agar when 
necessary. Supplements such as iron, BPS or fludioxonil, as well as solvent controls, were 
added to the agar containing medium prior pouring plates. RPMI plates were stored at 4 °C 
until use. Fludioxonil/ MeOH containing plates were used immediately for growth tests. C. 
albicans was incubated on agar plates in either Titramax/ Inkubator 1000 (Heidolph) or 
Multitron Shaker (Infors-HT) without shaking. After incubation, pictures of agar plates were 
taken with the GS-800 gel scanner and colors were occasionally inversed with Adobe 
Photoshop CS3 Extended for proper display if required.    
2.11 Microscopic analysis 
Microscopic analysis of culture was performed with CKX41/U-RFLT50 (Olympus). 10 µl of 
cell suspension were dropped on Superfrost glass slides (Menzel). Pictures of cultures were 
taken with ColorView SIS FireWire Camera 3.0 and analyzed with CellA^ 3.0 software 
(Olympus). For cell counting, 10 µl of diluted or not diluted cell suspensions were dropped on 
an Neubauer Improved counting chamber (Brand, 0.1 mm depth) and cells were counted 
under an Axioplan microscope (Zeiss, Jena). The total cell number ml
-1 
was determined by 
counting cells in all 25 small squares of 1 mm
2
 total surface area. The cell concentration was 
calculated as following: 
Cells ml
-1
 = Σ cells (25 small squares) ∙ 104 ∙ dilution factor 
2.12 In silico protein sequence analysis 
The amino acid sequence of C. albicans Bgl2p (orf19.4565) was obtained from the Candida 
Genome Database (CGD, http://www.candidagenome.org). BLAST of the C. albicans 
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SC5314 Bgl2p aa sequence was performed at UniprotKB (http://www.uniprot.org) and Bgl2p 
orthologs from C. dubliniensis (accession number B9WFS5), C. glabrata (Q6FTS0), C. 
tropicalis (C5M280), C. guilliermondii (A5DGI5) and C. lusitaniae (C4YA41) were 
identified respectively. The C. parapsilosis (CPAG 04005) Bgl2p ortholog was identified 
after performing BLAST in the Candida Database of the Broad Institute 
(http://www.broadinstitue.org). A putative Bgl2p ortholog from C. krusei could not be 
identified as the genome of this species was not yet sequenced and annotated at the time 
during which this work was performed. The presence of a GH17 domain in each of the 6 non-
albicans Candida species (NACS) orthologs was confirmed using Pfam 
(http://pfam.sanger.ac.uk/search). Bgl2p sequence from C. albicans ATCC102161 was 
similarly obtained from UniprotKB (P43070). While Bgl2p sequence from C. albicans WO-1 
was obtained from the CGD (CAWG_03569 ). The Bgl2p sequences of the C. albicans strains 
SC5314, WO-1, ATCC10261 and their orthologs from 6 NACS were subjected to multiple 
sequence alignment using ClustalW2 (http://www.ebi.ac.uk/Tools/clustalw2/index.html).  
2.13 Other equipment and materials 
Discovery Comfort pipettes (0.1 – 2 µl, 2–20 µl, 20–200 µl and 100-1000 μl) as well as 
Eppendorf Research pipettes (0.5 – 10 µl and 100 – 1000 µ) were used. Multichannel pipettes 
used were Brand Transferpette (20 – 200 µl) and Eppendorf Research (30 – 300 µl). Pipette 
tips (10 µl, 200 µl and 1000 µl) were purchased from Starlab. Glass pipettes from 
Hirschmann (20 ml, 10 ml, 5 ml and 2 ml) or plastic pipettes from Corning (25 ml, 10 ml and 
5 ml) were used in combination with Easypet® (Eppendorf) and CellMate Matrix (Thermo 
Scientific) pipetting helpers. For OD measurements by the µQuant microtiter plate reader, 
unsterile flat bottom 96 well plates (Ratiolab) or CytoOne (Starlab) 96 well plates were used. 
24 well plates as well as Petri dishes were purchased from Greiner. transparent 0.5 ml, 
46 
 
transparent 1.5 ml, light protected 1.5 ml and transparent 2 ml tubes were purchased from 
Eppendorf while Falcon tubes (50 ml centrifugation, 50 ml safe standing, 15 ml were obtained 
from Corning. For washing of C. albicans cells and preparation of protein extracts from C. 
albicans or E. coli, Eppendorf 5804R (Rotors A4-44, F34-6-38, F-45-30-11) or Eppendorf 
5415R centrifuges were mainly used. Biofuge fresco (Heraeus) was only occasionally used. 
5415 centrifuge (Eppendorf) was used for short spinning of protein extracts mixed with 
protein sample buffer after heating at 95 °C. Beckman Avanti® J-20XP was used for plasmid 
midipreps, while Heraeus Fresco17 (Thermo Scientific) was used for plasmid minipreps or 
DNA extraction from agarose gels. VF2 (Janke & Kunkel IKA Labortechnik) and 
VortexGenie 2 (Scientific Industries) were used as vortex apparatuses, while IKAMAG RCT, 
Heidolph MR2002 and Heidolph MR-82 served as magnet mixers. Microbial strains stocks 
were stored in a GFL – 80 °C freezer. Other freezers (- 20 °C or – 30 °C) and fridges used 
were AEG Electrolux, Liebherr Premium, Liebherr Profiline. Liebherr Glassline and Liebherr 
Ökosuper Premium. Ice machines used were manufactured by Ziegra.   
2.14 Preparation of texts and figures 
Preparation of texts and figures was performed with Microsoft® Office products, Paint and 
Adobe Photoshop CS3 Extended. Analysis of SDS- gels and western blot images was 
performed with Aida Image Analyzer v.4.15, when necessary.  
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Chapter 3 Results 
3.1 The cell wall antigen Bgl2p allows detection of C. albicans cells by 
monoclonal antibodies 
3.1.1 Background 
We aimed to identify cell wall proteins (CWPs), which could serve as diagnostic markers for 
C. albicans infections. The candidate proteins (antigens) had to comply with several 
characteristics:  
(i) Candidate proteins must be accessible for binding partners. This requires that 
the candidate protein must be permanently attached to the cell surface and 
exposed to be recognized by a binding partner. Thus, cell wall proteins (CWPs) 
are suitable targets.  
(ii) The target protein should be abundant to allow sensitive detection.  
(iii) It should have low homology to human proteins or to proteins from other 
pathogens or commensals.  
(iv) It should allow distinction of C. albicans infection from colonization. 
As the desired diagnostic monoclonal antibodies should be specific for C. albicans, the 
epitopes recognized by these antibodies should be unique for this fungus. However, many 
CWPs are not only conserved among Candida spp., but also among different fungi. We 
concentrated on the identification of unique peptide sequences from C. albicans CWPs. 
Corresponding peptides could be generated in vitro and diagnostic, monoclonal antibodies 
directed against their sequences could be generated by immunization in mice. A major 
disadvantage of peptide mediated immunization is that generated antibodies may not bind to 
the target protein in its native fold.  
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Suitable cell surface candidates for recognition by antibodies are antigenic proteins. Humoral 
immune recognition of pathogens is mediated by antibodies targeting epitopes of such 
proteins. 
A seven point strategy was followed for this project:  
(i) Identification of suitable candidates. For the identification of candidates, 
comprehensive literature search for strongest antigenic proteins was performed. 
In parallel, several methods were applied for extraction of cell surface proteins 
from C. albicans in order to identify the most abundant proteins.  
(ii) Studies on the suitable candidates. As mentioned above, any suitable candidate 
must be accessible for binding partners, and thus should be permanently 
attached to the cell surface. Taking in account the polymorphic nature of C. 
albicans, cell surface composition of this fungus is variable depending on 
morphology or environmental factors. Changing cell surface composition 
could help C. albicans to evade immune recognition (Brawner & Cutler, 1986; 
Nather & Munro, 2008), which suggests that C. albicans may change its cell 
surface composition during different growth and infection stages.  
(iii) Identification of unique peptide sequences of the desired candidate antigen.  
(iv) Production and synthesis of these peptides.  
(v) Production of monoclonal antibodies against peptide antigens.  
(vi) Selection of antibodies in terms of binding to the candidate antigen.  
(vii) Selected antibodies are evaluated by their ability to specifically recognize 
whole C. albicans cells.     
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3.1.2 Identification of Bgl2p as a target protein 
Several studies have been undertaken to identify antigenic proteins of C. albicans in both, the 
pre- and post-genomic era (Clancy et al, 2008; Gutierrez et al, 1993; Mochon et al, 2010; 
Pitarch et al, 2006; Pitarch et al, 1999; van Deventer et al, 1994). These studies have resulted 
in the identification of several proteins of cytosolic functions, such as glycolytic enzymes. As 
mentioned above (1.2.2.2), some of these proteins, such as Eno1p, Tdh3p, Adh1p or Tef1p 
were reported to have cell surface localization (Eroles et al, 1997; Gil-Navarro et al, 1997; 
Urban et al, 2003). However, as such proteins are highly conserved (Martinez et al, 1998), 
they were not considered as suitable candidates. On the other hand, more recent studies have 
used modern approaches to identify antigens of C. albicans. A 34 kDa protein, named Bgl2p, 
was found among a group of the most immunodominant proteins of C. albicans (Clancy et al, 
2008; Mochon et al, 2010; Pitarch et al, 2006). Simultaneously, our experimental 
investigation of abundant C. albicans cell surface proteins resulted in the isolation of this 
protein by almost every method applied, from both whole and disrupted cells (Table 4, Figure 
3.1.1 and Supplemental data 2).  
Table 4 – Bgl2p is isolated from C. albicans cell wall by different methods. 
Extraction 
method 
Zymolyase  
(disrupted cells) 
Hot Urea  
(disrupted cells) 
Hot SDS  
(disrupted cells) 
Heat  
(disrupted cells) 
Heat  
(whole cells) 
Bgl2p 
isolated + + - + + 
Several other proteins were identified by MS or MS/MS analysis. Among those proteins were 
proteins of cytosolic localization (See Supplemental data 2D), which were released by hot 
SDS treatment of cell walls. Heat extraction of whole cells, grown in RPMI + 10% FBS at 30 
°C, isolated members of the multicopper ferroxidase (MCFO) protein family (see 
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Supplemental data 2F and section 3.2.6). One member of this family was included in a group 
of the forty most serodominant antigens in acute candidemia patients (Mochon et al, 2010).   
Bgl2p is a cell wall ß-(1,3)-glucosyltransferase belonging to the glycosylhydrolase (GH)-17 
protein family (Chaffin, 2008). Homozygote Δbgl2 mutants were found attenuated in 
virulence in a murine model compared to an isogenic parental strain suggesting a role for this 
cell wall protein in virulence of C. albicans (Sarthy et al, 1997).  
Bgl2p is one of the most abundant proteins in the cell wall of C. albicans (Angiolella et al, 
2009). Furthermore, Bgl2p was also shown to interact with basic proline rich proteins (bPRP) 
of the human saliva, suggesting that Bgl2p has adhesion like properties (Jeng et al, 2005).  
However, the probably most important feature of C. albicans Bgl2p for this work is its 
antigenic property. It has been described as a highly antigenic protein, eliciting a strong 
antibody response in C. albicans infected patients (Clancy et. al, 2008; Mochon et al, 2010; 
Pitarch et al, 2006). This would mean that the immune system detects C. albicans by means of 
anti-Bgl2p antibodies (among others) and that Bgl2p is accessible for antibody binding in 
principle.   
Taking all existent data dealing with C. albicans Bgl2p together, this protein was judged to be 
an excellent candidate antigen for the development of diagnostic tools for identification of C. 
albicans in infected patients.  
3.1.3 Bgl2p is associated with the cell wall during different growth stages as well as 
during initial hyphal formation 
As C. albicans Bgl2p was reported to be secreted to medium supernatants (Sorgo et al, 2010), 
further studies were required to investigate attachment of Bgl2p to the cell wall of C. 
albicans.  
Bgl2p was isolated by short time boiling of whole overnight (17.5 h) C. albicans DAY286 
cells resuspended in PBS, pH 7.4 at 90 °C (Figure 3.1.1). The appearance at ca. 35 kDa and 
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comparison with an isolate derived from an equally treated Δbgl2 mutant, allowed initial 
identification of the Bgl2p band. Furthermore, mass spectrometric analysis (peptides 
IFLVGSEALYR, 1267.7 m/z; and AWGINVAVYEAFDEAWKPDTSGTSSVEK, 3057.4 
m/z) and N-terminal sequencing analysis (sequence MGDLAFNLGVKNDDG corresponds to 
Bgl2p starting position 19, i.e. after excision of an 18 aa signal peptide sequence (Angiolella 
et al, 2009)) confirmed the presence of Bgl2p. This protein was also released by the same 
method when PBS was exchanged by 25 mM Tris∙HCl pH 8.0 (not shown).  
The release of Bgl2p by heat is indicative for its non-covalent attachment to the C. albicans 
cell wall. This complies with previous knowledge on this protein (Chaffin, 2008). 
Supplementing PBS with reducing (DTT, ß-mercapthoethanol) or denaturing agents (SDS, 
urea) did not lead to significant increase in isolated Bgl2p amounts (not shown). To confirm 
that the Bgl2p found in isolates of boiled cells did not derive from medium supernatants due 
to inappropriate washing of cells, C. albicans DAY286 cells from the same culture were 
resuspended in PBS but left at room temperature (RT) for 10 min instead of being boiled at 90 
°C. The obtained supernatants apparently contained no protein (Figure 3.1.1).  
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Figure 3.1.1 – Extraction of Bgl2p from whole cells. 
SDS-PAGE analysis of proteins extracted by heating whole yeast cells of C. albicans DAY286 or Δbgl2 in PBS. 
Cells were cultivated overnight in YPD. As a control, DAY286 was resuspended in PBS and kept at RT. Gel was 
run for 30 min at 80V and 100 min at 120 V. 
Next, Bgl2p was isolated from whole DAY286 cells from different growth phases. Thus, cells 
were grown in YPD at 30 °C for different periods until an OD600 of 0.4, 1.5 or 3.2 was 
reached respectively. Bgl2p was found to be present in all extracts, meaning that Bgl2p was 
attached to the cell wall during all growth phases (Figure 3.1.2A). Bgl2p was also found to be 
associated with the cell wall in the early stages of hyphal formation at 37 °C in RPMI medium 
supplemented with 10% fetal bovine serum (FBS) (Figure 3.1.2B). See Supplemental data 3 
for cell morphology.  
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Figure 3.1.2 – Studies on the attachment of Bgl2p to the C. albicans cell wall during different 
growth stages and morphologies. 
SDS-PAGE analysis of proteins extracted by heating whole cells of C. albicans DAY286 and Δbgl2. (A) Cells 
were cultivated in YPD medium for different periods until cultures reached the indicated OD600 before proteins 
were extracted. Arrows in the gel indicate Bgl2p. The gel was run for 2 h at 120 V. Lane 1: marker, lanes 2, 4 
and 6: DAY286 extracts, lanes 3, 5 and 7: Δbgl2 extracts. (B) Cells were cultivated in RPMI medium 
supplemented with 10% FBS at 37 °C for 3 h for initial hyphal formation. The gel was run for 2 h and 43 min at 
120 V (excerpt of the Coomassie stained SDS-gel is shown). 
3.1.4 Identification of unique C. albicans Bgl2p peptides and generation of anti-Bgl2p 
monoclonal antibodies 
We aimed to identify unique peptides of Bgl2p which could be synthesized and used for 
immunization in mice for monoclonal antibody production. The identification of suitable 
peptides was performed in cooperation with projects partners (Yvonne Mayer, 
Microdiscovery GmbH, Berlin, Germany). Favorable peptides should comply with the 
following criteria: 
(i) Peptides should be 10 – 25 aa long.  
(ii) The peptide sequences should be largely conserved among C. albicans strains. 
Furthermore peptide sequences must be specific for C. albicans and have low 
homologies in proteins from non-albicans Candida species (NACS).  
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(iii) Peptides should have low or no homology to proteins from other pathogens or 
humans.  
(iv) The peptides sequence in the protein must be accessible for antibodies.   
Only three C. albicans strains have been sequenced when the analysis was conducted. These 
are SC5314, the WO-1 strain and ATCC10261. Multiple sequence alignments (MSA) showed 
a high conservation of the Bgl2p sequence not only among the three C. albicans strains 
mentioned above, but also among several Candida spp. (see Supplemental data 4).  
Conserved peptides forming α-helices were analyzed for their ability to serve as target 
sequences (by Yvonne Mayer). Unfortunately, the 3D-structure of C. albicans Bgl2p is not 
yet elucidated. Thus, C. albicans 3D-structure was modeled according to the published 3D-
structure 1aq0 of a ß-(1,3)-(1,4)-glucanase from Hordeum vulgare. This enzyme showed 
highest score in paired sequence alignments with Bgl2p, among all known 3D-structures of 
GH17 members found at the PDB database (http://www.rcsb.org/pdb/home/home.do). 
However, the identity between both proteins did not exceed 30%, suggesting a poor quality of 
the obtained model.   
Nevertheless, two peptides, termed a10 (SVENAADQWQKGIC) and a7/8 
(PAIDAADVVYSNSFSYW), were found identical in all three C. albicans strains. a10 was 
unique for C. albicans with only one E246K substitution in C. dubliniensis (Figure 3.1.3A). 
In contrast, a7/8 was conserved in C. dubliniensis (Figure 3.1.3B).  
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Figure 3.1.3 – Multiple sequence alignment (MSA) of Bgl2p peptides.  
MSA were performed for (A) a10 and (B) a7/8 from three different C. albicans strains and six different NACS. 
Alignments were performed using CLUSTALW2 and displayed with the Jalview editor 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). Amino acid numbers, lines and species description were added to 
the Jalview displayed MSA.  
A search for similar sequences from bacteria, fungi, archaea and humans was conducted in 
NCBI (performed by Yvonne Mayer, see Supplemental data 5). For peptide a10, only one 
relevant hit from Cellulomonas flavigena with a score of 52.0 was found. Peptide a7/8 had 
several hits from different yeasts including L. elogisporus, D. hansenii, Pichia stipitis or 
Yarrowia lipolytica.  
The selected peptides must be exposed for binding partners and thus should be present on the 
proteins outer region rather than being hidden inside the protein fold.  
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a10 forms an α-helix according to the modeled structure based on 1aq0. The sequence a7/8 
should form two short α-helices (Yvonne Mayer, personal communications). α-helices could 
be located on the proteins surface if they are pre-dominantly made of amino acids with polar 
side chains. a10 indeed mainly consists of amino acids with polar side chains, in contrast to 
a7/8, which is mainly made of non-polar or weakly polar side chains (Table 5).   
Table 5 – Distribution of amino acids with polar and non-polar side chains in peptides a10 
and a7/8 (single letter code for amino acids). 
Peptide Length 
(aa) 
Sequence Polar side 
chains 
Non-polar side 
chains 
Side chains 
with weak 
polarity 
a10 14 SVENAADQWQKGIC S, E, N, D, Q 
(2x), K, G, C 
V, A (2x), I W 
a7/8 17 PAIDAADVVYSNSFSY
W 
D (2x), S (2x), N P, A (3x), I, V (2x), 
F 
Y (2x), W 
However, with help of the PyMol v0.99 (DELANO SCIENTIFIC, USA) software, both 
sequences were predicted to be located in the external parts of the modeled protein (Figure 
3.1.4). Antibodies raised against short synthetic peptides have been found to bind the 
respective sequences in native proteins, if these sequences are present on the surface of the 
corresponding protein (Lerner, 1982). The peptides a7/8 and a10 were synthesized by Dr. 
Werner Tegge (CBIO, HZI, Braunschweig, Germany) and used for immunization in Balb/c 
mice (Dr. Nicole Schliebe, Institute for Biochemistry and Biology, University of Potsdam, 
Germany, personal communication). Peptide a7/8 was modified at the N-terminus by adding a 
cysteine residue to allow coupling to carrier proteins. Immunization of mice and selection of 
positive hybridoma cell culture supernatants was performed by project partners (Prof. Katja 
Heilmann and co-workers, Institute for Biochemistry and Biology, University of Potsdam).  
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Figure 3.1.4 – Localization of a7/8 and a10 in a modeled structure of C. albicans Bgl2p based on 
the 1aq0 structure of a ß-(1,3)-(1,4) glucanase from H. vulgare.  
Localization of peptides a7/8 (PAIDAADVVYSNSFSYW) and a10 (SVENAADQWQKGIC) was predicted in a 
modeled structure based on the structure 1aq0 (http://modbase.compbio.ucsf.edu). a7/8 and a10 are highlighted 
in white. Note that the protein structure is differentially rotated in each image for proper display of the desired 
peptides. 
3.1.5 Recombinant expression and purification of C. albicans rBgl2p-SP under non-
denaturing conditions 
Generated anti-7/8 or anti-a10 antibodies had to be assessed as to their binding to purified 
native Bgl2p.The isolation of Bgl2p under non-denaturing conditions was achieved by 
Zymolyase treatment of C. albicans cell walls. However, extracted Bgl2p amounts by 
Zymolyase digestion of cell walls were judged as relatively low (see Supplemental data 2A), 
so that further purification steps seemed incapable of providing enough protein. Thus, 
recombinant protein expression was followed as an alternative strategy. The C. albicans 
BGL2 (orf19.4565) sequence was acquired from the Candida Genome Database (CGD) 
(Inglis et al, 2012). Based on this sequence, a CaBgl2p encoding gene was designed by Prof. 
Dr. Peter Müller (RDIF, HZI, Braunschweig) with restriction sites altered by silent nucleotide 
substitutions to facilitate easier cloning. Furthermore, coding sequences for 3x FLAG- and 8x 
His-Tags were included at the 3’ end followed by a stop codon. A NcoI digestion site was 
58 
 
included after the coding sequence of an 18 aa signal peptide (Angiolella et al, 2009) which 
allows cloning of two versions of the gene, one which encodes the full length Bgl2p (rBgl2p), 
while the other encodes Bgl2p lacking the signal peptide (rBgl2p-SP). As the first amino acid 
after the signal peptide sequence in Bgl2p is methionine, there was no need for insertion of an 
artificial methionine codon. Figure 3.1.5A shows a schematic illustration of the 
Ca_BGL2_FLAG3x_His8x, encoding recombinant Bgl2p (rBgl2p). See Supplemental data 1 
for the sequence of the Ca_BGL2_FLAG3x_His8x gene.  
 
Figure 3.1.5 – Design of Ca_BGL2_FLAG3x_His8x encoding recombinant Bgl2p (rBgl2p). 
(A) Schematic illustration of Ca_BGL2_FLAG3x_His8x, encoding for recombinant Bgl2p (rBgl2p) with 
respective restriction sites used for cloning of each version. (B) Sequence alignment (ClustalW2; displayed with 
Jalview) of rBgl2p and the native C. albicans Bgl2p sequences. Ca_BGL2_FLAG3x_His8x was translated using 
http://web.expasy.org/translate/. FLAG and HIS tag sequences are indicated.  
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The resulting amino acid sequence was aligned with Bg2lp sequence obtained from the CGD 
to confirm correct sequence (Figure 3.1.5B). Ca_BGL2_FLAG3x_His8x was synthesized by 
GENEART AG (Regensburg, Germany). 
Experimental work was restricted to Ca_BGL2_FLAG3x_His8x_-SP3 so far, as Bgl2p 
present in the C. albicans cell wall lacks a signal peptide (Angiolella et al, 2009).  
rBgl2p-SP was expressed from E. coli Ca_BGL2_FLAG3x_His8x_-SP3. Four different IPTG 
concentrations (0, 62.5, 125 and 250 µM) were tested for best expression levels of rBgl2p-SP 
under non-denaturing conditions. Best expression of the target protein was obtained when no 
IPTG was added (Figure 3.1.6A). Thus, addition of IPTG was omitted in all later experiments. 
rBgl2p-SP was successfully purified (> 90%) by means of the N-terminal 8x His-TAG. This 
was achieved by coupling the selectivity of Ni-NTA beads with separation by molecular 
weight in a PD-10 sepharose column. Among six analyzed elution fractions, fractions shown 
in lanes 5 and 6 showed highest rBgl2p-SP content (Figure 3.1.6B), while fractions shown in 
3 and 4 showed no content. Fractions shown in lanes 5 – 8 were pooled, concentrated, 
desalted and eluted with NP buffer by PD-10 columns. The purified protein was concentrated 
again by Vivaspin6 (3 kDa MWCo) before being applied on SDS-gel.  The purified protein 
was applied twice on the same SDS-gel. After SDS-PAGE, one sample was subjected to 
coomassie staining, while the other was blotted on a PVDF membrane and probed with anti-
FLAG antibody (Figure 3.1.6C and D). 
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Figure 3.1.6 – Expression and purification of rBgl2p-SP from E. coli RosettaTM 2 (DE3). 
 (A) Strain Ca_BGL2_FLAG3x_His8x_-SP3 was cultivated and cell lysate was prepared as indicated in 2.3.4. 
Four different IPTG concentrations (0, 62.5, 125 and 250 µM) were tested for best expression levels of rBgl2p-
SP under non-denaturing conditions. Lysate was run by SDS-PAGE and proteins were blotted on PVDF 
membrane. Blot was probed with anti-FLAG for rBgl2p-SP determination. Blot was exposed for 60 seconds. (B) 
SDS-PAGE (3h, 120 V) followed by Coomassie staining of crude lysate and purified rBgl2p-SP. Lane 1: marker, 
lane 2: crude lysate, lanes 3 – 8: rBgl2p-SP elution fractions. (C) SDS-PAGE (2h, 120 V) followed by coomassie 
staining of pooled elution fractions shown in lanes 5 – 8 in (B). Fractions were concentrated, desalted and eluted 
with NP buffer by PD-10 columns. The sample was concentrated again before being applied on SDS-gel. 
Identity of Bgl2p band (ca. 36 kDa) was proven by MS/MS analysis. (D) A sample from the same purified 
rBgl2p-SP shown in (C) was applied on the same gel and then blotted on a PVDF membrane. The membrane 
was probed with anti-FLAG antibody. The blot was exposed for 50 seconds.   
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3.1.6 Qualitative evaluation of anti-a7/8 and anti-a10 antibodies for binding to purified 
rBgl2p-SP 
Cell culture supernatants of hybridoma cell lines were evaluated in Enzyme Linked 
Immunosorbent Assay (ELISA) for binding to the respective antigen (a7/8 or a10) by project 
partners (Prof. Katja Heilmann and co-workers, Institute for Biochemistry and Biology, 
University of Potsdam). Supernatants which are named C25 contained antibodies which 
recognize peptide a10, while those starting with C26 contained antibodies recognizing a7/8 
(Natalia Maier, Institute for Biochemistry and Biology, University of Potsdam). Positive 
supernatants were evaluated for their binding to rBgl2p-SP, expressed and purified under non-
denaturing conditions. rBgl2p-SP was dropped on PVDF membranes (dot blot) and 
membranes were incubated with the respective supernatant and subsequently with an HRP-
conjugated secondary antibody. All tested anti-a10 supernatants showed clear binding to 
rBgl2p-SP, while most anti-a7/8 (e.g. C26FC11F7) did not bind to the protein (Figure 3.1.7 
and Supplemental data 6). To confirm presence of the rBgl2p-SP protein, membranes treated 
with C25JA11B10 or C26FC11F7 were stripped and probed with anti-FLAG antibody 
(Supplemental data 6).  
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Figure 3.1.7 – Dot blots analysis of binding of several hybridoma cell culture supernatants 
to rBgl2p-SP. 
  
(A) rBgl2p-SP (ca.  227 ng) was dropped on PVDF membranes. Membranes were blocked, washed with TBS 
containing 0.05% (v/v) Tween-20 and incubated overnight with the respective hybridoma cell culture 
supernatants and subsequently with HRP-linked secondary antibody. Blots were exposed for 30 sec each. A 
scheme of the blots is also shown. rBgl2p-SP used in this experiment derived from a different purification than 
indicated under Figure 3.1.6. The purification control is shown in (B). (B) SDS-PAGE analysis of rBgl2p-SP 
purification. Gel ran for 4 h at 120 V. Identity of Bgl2p band (ca. 36 kDa) was proven by MALDI-TOF MS 
analysis. 
Table 6 summarizes the results obtained with the tested supernatants by dot blot detection of 
rBgl2p-SP.   
Table 6 – Binding of antibodies present in tested hybridoma cell culture supernatants to 
rBgl2p-SP by dot blot analysis. 
Supernatant Bound rBgl2p-SP 
C25HD4H4 Yes 
C25HD4H8 Yes 
C25JA11B10 Yes 
C25JA11E5 Yes 
C25JA11H5 Yes 
C26FC11F7 No 
C26GH11E7 No 
C26GH11E9 Yes 
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3.1.7 Evaluation of C25HD4H4 and C25HD4H8 binding to viable C. albicans cells 
In order to evaluate binding of the anti-a10 antibodies to viable C. albicans, flow cytometric 
analysis of SC5314, DAY286 and Δbgl2 strains was performed as indicated in 2.9. As 
hybridoma cell culture supernatants contained 15% FBS (Dr. Nicole Schliebe, Institute for 
Biochemistry and Biology, University of Potsdam, personal communication), C25HD4H4 and 
C25HD4H8 were each concentrated 2.3 fold by Vivaspin columns of 50 kDa MWCo in order 
to remove lower molecular weight protein contaminants, while enriching the respective 
antibodies. Binding of C25HD4H4 and C25HD4H8 was evaluated as these supernatants 
showed the strongest binding to rBgl2p-SP in dot blot analysis (Figure 3.1.7). As Bgl2p 
content increased during stationary phase of growth (Figure 3.1.2), we first tested the binding 
of these two supernatants to stationary phase cells.  
As can be taken from Figure 3.1.8A, C25HD4H4 and C25HD4H8 bound cells from stationary 
phase, of both SC5314 and DAY286 (both BGL2
+
), but not to Δbgl2 cells, as the peak pattern 
between BGL2
+
 and Δbgl2 cells was distinct. The histograms of unstained cells (PBS), 
resembled those of cells which were not bound by fluorescent probes. Cells of all three strains 
treated only with the secondary antibody (anti-mouse-IgG), showed no unspecific binding by 
this antibody. Binding of C25HD4H4 was stronger compared to C25HD4H8 as a 
subpopulation (lower fluorescence range) of SC5314 was not detected by C25HD4H8. As a 
positive control, SC5314 cell surface proteins were biotinylated and subsequently stained with 
fluorescently labeled streptavidin (Figure 3.1.8B).  
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Figure 3.1.8 – Flow cytometric analysis of C25JHD4H4 and C25HD4H8 treated cells. 
(A) C. albicans SC5314, DAY286 or Δbgl2 were incubated with each of the 2.3 fold concentrated mouse 
hybridoma cell culture supernatants C25HD4H4 or C25HD4H8 containing monoclonal anti-a10 antibodies, 
followed by incubation with Alexa fluor 488 anti-mouse IgG antibody and analyzed by flow cytometry. For 
negative controls, supernatants were substituted by the same volume of PBS or only PBS was used during all 
incubation steps respectively. (B) SC5314 cell surface proteins were biotinylated with 1 mg ml
-1
 EZ-Link Sulfo-
NHS-LC-LC-Biotin and subsequently were incubated with Alexa fluor 488 Streptavidin. For negative control, 
biotin was substituted by the same volume of PBS pH 8.0 and subsequently incubated with Alexa fluor 488 
Streptavidin. 
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3.1.8 Discussion 
Numerous C. albicans proteins are known for their antigenic properties, however, most of 
these proteins are either glycolytic enzymes, elongation factors, ribosomal or ribosome 
associated proteins. Such proteins are highly conserved either among kingdoms, or even 
among all organism classes. Moreover, the presence of such proteins on the cell surface of C. 
albicans is often disputed (Klis et al, 2009). This would deem such proteins as inappropriate 
for diagnostic approaches.  
Hwp1p is a unique C. albicans cell wall protein and parts of this protein were previously used 
in C. albicans diagnostics (Lain et al, 2007). However, this protein is only present in the cell 
wall during the hyphal morphology (Staab et al, 1996). Yet abundant, such hyphae-specific 
CWPs were also judged as inappropriate. The yeast morphology is important for 
dissemination of yeast cells and is thus important during the initial infection process (Saville 
et al, 2003; Thompson et al, 2011). As rapid detection of C. albicans cells during the early 
stages of infection is of high value; thus, target CWPs present only on the surface of true 
hyphae could lead to yeast cells being not detected. Patients suffering under early stage 
Candidiasis would thus not be correctly diagnosed. 
Bgl2p is a protein which complies with most of the characteristics mentioned under 3.1.1. We 
used several methods of cell surface protein extraction from both whole and disrupted cells. 
Bgl2p was frequently found in almost all of those different extracts, confirming that such 
observations were not method dependent. Bgl2p could only not be detected in hot SDS 
extracts. This was surprising, as Bgl2p is known to be a non-covalently bound CWP. 
Identification of Bgl2p in hot SDS extracts might have been prevented by more abundant 
proteins of the similar molecular weight in SDS-PAGE, if present in the same gel slice as 
Bgl2p.  
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Klis and co-workers had previously suggested that Bgl2p, along with other non-covalently 
bound CWPs, might be washed away from the cell wall by shaking at 200 rpm (Sorgo et al, 
2010). Published Bgl2p extraction methods from C. albicans or S. cerevisiae included 
mechanical disruption of cells before subsequent release from the cell wall by heat or 
Zymolyase treatment (Angiolella et al, 2009; Mrsa et al, 1993, Sarthy et al, 1997). Indeed, our 
own experiments which involved mechanic disruption of cells by grinding or via a 
microdismembrator did not lead to satisfying amounts of Bgl2p (see Supplemental data 2), 
suggesting that Bgl2p was partly lost during disruption of cells and subsequent washing of 
cytosolic contaminants. Thus, we needed to develop a reliable method to study Bgl2p content 
of cell walls after different cultivation conditions. We extracted Bgl2p by heating whole cells 
at 90 °C for 10 min. The high temperatures were sufficient to release Bgl2p from the cell wall 
without combination of heat with reducing or denaturing agents. As heat disrupts non-
covalent bonds (e.g. hydrogen bonds), this correlates with previous knowledge on Bgl2p as a 
non-covalently bound CWP (Chaffin, 2008). Even though Bgl2p levels markedly increased in 
stationary phase cells, this protein was found to be permanently attached to the cell wall, 
which is a prerequisite for accessibility of cells by anti-Bgl2p antibodies. Additionally, Bgl2p 
was found in extracts derived from cells at initial yeast-to-hyphae switch. This indicates that 
such cells found during the early phase of infection could also be detectable by anti-Bgl2p 
antibodies.  
Serum anti-Bgl2p antibodies were suggested as diagnostic biomarkers of systemic candidiasis 
(SC), as the anti-Bgl2p IgG response of SC patients was stronger than of non-SC individuals 
(Pitarch et al, 2006). This is an indicator of the accessibility of this protein by antibodies 
during C. albicans infection. The same authors suggested that high levels of anti-Bgl2p 
antibodies represent a defense mechanism against SC and confer protection of the host from 
SC. Furthermore, these findings indicate that Bgl2p is an appropriate target protein to 
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distinguish C. albicans infection from colonization. Other works have also included Bgl2p 
among a group of the most antigenic proteins of C. albicans (Clancy et al, 2008; Mochon et 
al, 2010). 
The presence of Bgl2p on the cell surface was also experimentally confirmed (Hernaez et al, 
2010), as well as being one of the most abundant proteins in the cell wall of C. albicans 
(Angiolella et al, 2009). The function of Bgl2p as an adhesin (Jeng et al, 2005) further 
confirms its association with the cell surface and implicates a role in pathogenicity. The latter 
assumption is further strengthened by the reduced pathogenicity of the Δbgl2 mutant in a 
murine model of infection (Sarthy et al, 1997). Thus, Bgl2p appeared to be a strong candidate 
target protein.  
However, members of the Bgl2p family are present in several ascomycetes (Mouyna et al, 
1998; Mrsa et al, 1993; Weig et al, 2004). BLAST search also showed a relatively high 
conservation of this enzyme within Candida clade species (see Supplemental data 4). Antisera 
raised against Bgl2p from S. cerevisiae could identify C. albicans Bgl2p in western blot 
experiments (Sarthy et al, 1997). Therefore, epitopes which should be recognized by anti-
Bgl2p antibodies in diagnostic approaches had to be unique for C. albicans Bgl2p.  
The search for unique C. albicans Bgl2p epitopes resulted in two peptides, termed a10 and 
a7/8 respectively. These peptides were found to be conserved in the three C. albicans strains 
mentioned above and had low similarities with sequences from different organismal classes. 
Furthermore, peptide a10 was unique for C. albicans (see Supplemental data 4).  
The two peptides a7/8 and a10 were used for antibody production in mice. Anti-peptide 
antibodies can be highly reactive with the native protein incorporating the same primary 
amino acid sequence, provided such sequences are not buried within the proteins fold (Lerner, 
1982).  
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In order to evaluate antibody binding to the native protein, Bgl2p had to be extracted and 
purified under non-denaturing conditions. This was accomplished by Zymolyase digestion of 
the ß-(1,3)-glucan network of the cell wall. However, extracted amounts of Bgl2p were 
judged as relatively low after SDS-PAGE analysis so that further purification steps seemed to 
be unrealistic. We thus decided to recombinantly express Bgl2p and opted for E. coli over 
yeast as expression system. In contrast to yeast, Bgl2p expressed in E. coli would lack post-
translational modifications such as glycosylation (Lain et al, 2008). However, in yeast 
expression systems, rBgl2p would be incorporated into the cell wall requiring special 
treatment for extraction (i.e. Zymolyase digestion), leading to similar problems as in C. 
albicans (see above). Furthermore, overexpression of ScBGL2 in S. cerevisiae led to 
significant decrease of the growth rate of cells (Mrsa et al, 1993). 
Supernatants which contained either anti-a10 or anti-a7/8 antibodies were evaluated for 
binding against recombinant Bgl2p lacking the signal peptide sequence (rBgl2-SP), expressed 
and purified under non-denaturing conditions. All five tested anti-a10 supernatants bound 
rBgl2p-SP in dot blots, while two of three tested anti-a7/8 supernatants did not. An 
explanation for this behavior could be that peptide a7/8 mostly consists of amino acids with 
non-polar side chains (Table 5), rendering it less soluble and thus probably hidden inside 
rBgl2p-SP. In contrast to this, peptide a10 largely consists of amino acids with polar side 
chains, suggesting that this amino acid sequence might be present on the protein’s surface. 
Thus, more polar alpha-helices are better accessible for antibody binding. However, peptide 
a7/8 is detectable in principle by antibodies as C26GH11E9 bound rBgl2p. This depends on 
the localization of the respective epitope which is recognized by each antibody. Modeled 
structures of C. albicans Bgl2p based on 1aq0 from H. vulgare suggested that both a7/8 and 
a10 are largely present in the outer parts of protein. However, because of the low identity (ca. 
30%) between C. albicans Bgl2p and the H. vulgare protein the modeled structure could not 
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reflect real localization of a7/8 and a10. As the concentration of antibodies in such hybridoma 
cell culture supernatants is unknown, failure of anti-a7/8 containing supernatants (e.g. 
C26FC11F7 and C26GH11E7) to bind rBgl2p-SP could also simply be due to low anti-a7/8 
titers in those supernatants.  
C25HD4H4 and C25HD4H8 showed strongest binding to rBgl2p-SP among all tested 
supernatants. Previously, these two supernatants showed strong signals when tested in ELISA 
against a10 (Dr. Nicole Schliebe, Institute for Biochemistry and Biology, University of 
Potsdam, personal communication). Both C25HD4H4 and C25HD4H8 could bind to C. 
albicans SC5314 (WT) as well as to DAY286 cells. Fluorescence signals from SC5314 and 
DAY286 were clearly distinct from those of Δbgl2 cells treated with the same supernatants, 
which were similar to the peaks of the negative controls. This indicated that components of 
the two supernatants could bind to exposed cell surface structures of SC5314 and DAY286 
which were missing in Δbgl2 cells. The only difference in the genomes of DAY286 and 
Δbgl2 is the lack of the BGL2 gene in the latter cells (Table 1). This is a strong indicator that 
Bgl2p is the target of the anti-a10 antibodies present in C25HD4H4 or C25HD4H8.  
However, the histograms showed background fluorescence resulting probably from unspecific 
binding of supernatant components to Δbgl2. Hybridoma cell culture supernatants contain a 
variety of FBS derived proteins, including bovine antibodies which may cross-react with cell 
surface structures of C. albicans cells and might be bound by the fluorescent anti-mouse IgG 
secondary antibody.  
Unfortunately, no purified anti-a10 antibodies were obtained from the project partners within 
the time of this thesis. This was due to major problems with antibody production and 
purification. Thus, final conclusions about quality, specificity and sensitivity of anti-a10 
antibodies cannot be made until the purified anti-a10 monoclonal antibodies are provided. 
Future experiments are further discussed in Chapter 4. 
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3.2 Involvement of the mitogen activated protein kinase Hog1p in the 
response of C. albicans to iron availability   
We have isolated proteins belonging to the multicopper ferroxidase (MCFO) class of enzymes 
from C. albicans by heating whole cells (see Supplemental data 2F and section 3.1.2). 
Members of this class are part of the high affinity iron uptake (HAIU) system which is 
induced in C. albicans during conditions of restricted iron (Lan et al, 2004). However, several 
components of the HAIU system, including genes encoding MCFO members, were found to 
be regulated by a variety of factors other than iron availability, such as pH (Bensen et al, 
2004) or antimycotic treatment (Liu et al, 2005). Furthermore, several genes encoding HAIU 
proteins were found to be de-repressed in a Δhog1 deletion mutant (Enjalbert et al, 2006) 
pointing to an involvement of the HOG pathway in regulating iron uptake.  
Additionally, the MCFO Fet34p was found among a group of the most serodominant 
antigenic C. albicans proteins together with the ferric reductase Fre10p (Mochon et al, 2010). 
The state of iron restriction in addition to the physiological pH present in human serum, 
probably leads to enhanced expression of MCFOs, thus increasing their abundance, which is a 
requirement for diagnostic target proteins. However, the regulation of MCFO expression 
seems to be very complex. Moreover, copper dependent ferroxidase proteins are not only 
present in different fungi, but also in humans (Kosman, 2002), thus complicating their use as 
target proteins for diagnostic purposes.  
However, as the expression of MCFO members was regulated by both, iron availability as 
well as the final MAP kinase of the HOG pathway Hog1p, we wondered whether a role for 
Hog1p exists in response to iron availability. Especially, as the role of signaling pathways in 
the regulation of cellular iron homeostasis was still unknown.  
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As mentioned in 1.2.6, C. albicans Hog1p responds to different stress situations including 
oxidative stress and oxidative stress conditions are induced by excess of free iron. 
Furthermore, C. albicans has been found to grow well during iron overload conditions as well 
as associated with iron overload diseases (Caroline et al, 1969; Minn et al, 1997). For these 
reasons, we were interested in studying the response of C. albicans to high iron 
concentrations with respect to a potential role of Hog1p in this response. The heat extraction 
method leading to the isolation of MCFOs can thus help to identify regulatory mechanisms of 
iron uptake in C. albicans.  
3.2.1 Iron induced C. albicans flocculation in a concentration dependent manner 
During cultivation of C. albicans SC5314 (WT) in RPMI containing different FeCl3 
concentrations (0, 1, 5, 7.5, 10, 20 and 30 µM) at 30 °C, we observed flocculation of cells in 
an iron concentration dependent manner. Flocs of cells could be seen at 5 µM and visibly 
increased from 7.5 to 30 µM Fe
3+
. Flocculation was also induced when 30 µM FeSO4 was 
used as sole iron source instead of FeCl3. However, flocculation in response to FeSO4 was 
less pronounced at that iron concentration compared to 30 µM FeCl3, as quantified by 
sedimentation rates (Figure 3.2.1A and B). Quantification of flocculation was accomplished 
by determination of the sedimentation rate of cells as previously described (see 2.4) (Gregori 
et al, 2011).  
Flocculation was also induced in yeast nitrogen base (YNB) medium containing 30 µM FeCl3 
compared to 1.2 µM (basal Fe
3+
 concentration in YNB medium according to the 
manufacturer), thus showing that the induction of flocculation was independent from the used 
medium (see Supplemental data 7).   
Cells may possess internal iron stores from pre-cultivation in an iron sufficient medium. Thus, 
we investigated whether the iron content of the medium used during pre-cultivations 
influenced the dependence of the flocculent phenotype on the iron concentration in RPMI.  
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C. albicans was either pre-cultivated in a medium with sufficient iron, i.e. the rich yeast 
extract-peptone-dextrose (YPD) medium, or starved for iron by pre-cultivation in a medium 
with restricted iron availability (RIM). The RIM resulted from addition of the iron chelator 
bathophenanthroline disulfonate (BPS) to the YPD medium. As shown in Figure 3.2.1C, 
sedimentation rates, i.e. flocculation, due to exposure to 30 µM Fe
3+
 were independent on the 
pre-cultivation medium: WT cells starved for iron by pre-cultivation in RIM flocculated upon 
exposure to 30 µM Fe
3+
 with a similar sedimentation rate as cells pre-cultivated in YPD. 
During all later experiments, C. albicans was pre-cultivated in YPD and 30 µM FeCl3 were 
used as iron source in the respective media used for working cultures unless it is mentioned 
otherwise. 
Interactions between cells, which lead to the formation of cell aggregates or flocs, occur via 
constituents of the cell wall, which favor physical (hydrophobic or electrostatic) or specific 
biochemical interactions. The cell wall of C. albicans comprises proteins which are frequently 
mannosylated and attached to the backbone of the cell wall formed by glucans and chitin 
(Chaffin, 2008). To obtain further information on the background of the flocculent phenotype, 
we inhibited protein biosynthesis by cycloheximide (CHX) 15 min prior to the incubation 
with iron. A reduction in flocculation was observed after iron addition compared to an equally 
treated methanol control (Figure 3.2.1D). The requirement of protein synthesis for 
flocculation was confirmed for the reference strain DAY286 (see Supplemental data 8A and 
B). Thus, protein synthesis seemed to be required for induction of iron dependent 
flocculation, indicating the activation of a specific response.  
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Figure 3.2.1 - Iron induced concentration dependent flocculation of C. albicans cells.  
(A) Microscopic analysis. C. albicans SC5314 (WT) was incubated with different FeCl3 concentrations 
(indicated at the top left hand of each sub panel) or with 30 µM FeSO4 in RPMI at 30 °C for 2 h. (B) Relative 
sedimentation rates of WT cells. Flocculation of cells was triggered by 30 µM FeCl3 or 30 µM FeSO4 in RPMI 
and sedimentation rates were determined after incubation at 30 °C for 2 h. Means and standard deviations of 
three independent samples are shown (n = 3). ** denotes P < 0.05 (student’s t-test). (C) Relative sedimentation 
rates of WT cells pre-cultured in the sufficient iron (YPD) or restricted iron medium (RIM) at 30 °C for 3 h. 
Flocculation of cells was triggered by 30 µM FeCl3 in RPMI and sedimentation rates were determined after 
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incubation at 30 °C for 2 h. Means and standard deviations of three independent samples are shown (n = 3). *** 
denotes P < 0.001 (student’s t-test). (D) Microscopic analysis of cycloheximide (CHX) or MeOH pre-treated 
cells. C. albicans SC5314 was pre-treated either with 500 µg ml
-1
 CHX or MeOH in RPMI at 30 °C for 15 min. 
Iron or water were subsequently added and cells were incubated at 30 °C for 2 h. 
3.2.2 High extracellular iron levels led to accumulation of intracellular ROS 
Iron is a potent inducer of reactive oxygen species (ROS) under aerobic conditions, as ferric 
iron is efficiently reduced to ferrous iron by superoxide formed as byproduct of respiration. 
The resulting ferrous iron is oxidized by hydrogen peroxide, resulting in the extremely 
reactive hydroxyl radical. Thus, uptake of iron leads to the accumulation of toxic ROS and, 
correspondingly, accumulation of ROS can be used as indicator of iron uptake, if all other 
conditions are kept constant. ROS levels were determined using CM-H2DCFDA which is a 
cell permeable, oxidant sensitive agent widely used for intracellular ROS determination (see 
2.5) (Alonso-Monge et al, 2009; Dhamgaye et al, 2012; Lupetti et al, 2002; Pieri et al, 2006). 
Compared to a water control, exposure of cells to 30 µM (high) but not to 1 µM (low) ferric 
iron led to an increase in ROS generation by 15 - 40%. This effect could be reversed by the 
ROS scavenger N-acetyl cysteine (NAC), when added to the cells together with iron (Figure 
3.2.2A).  
Flocculation is frequently induced in yeasts as a response to stress (Gregori et al, 2011; 
Verstrepen & Klis, 2006). As we had observed that high iron levels (30 µM) induced both 
flocculation as well as ROS accumulation while 1 µM Fe
3+
 did not, we investigated whether a 
relationship exists between the flocculation phenotype and iron induced oxidative stress. We 
determined the sedimentation rates of cells exposed to 30 µM iron and of cells exposed to the 
same iron concentration together with NAC. However, NAC did not prevent iron induced 
flocculation and the same sedimentation rate was obtained from the two data sets (Fig 
3.2.2B). Thus, iron induced flocculation and ROS accumulation were not related to each 
other.  
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Figure 3.2.2 - High extracellular iron concentrations increased intracellular ROS levels.  
(A) Determination of intracellular ROS production. WT cells were exposed to 0 (H2O control), 1 or 30 µM FeCl3 
in RPMI at 30 °C for 10 min. Additionally, cells were exposed to 30 µM FeCl3 together with 10 mM NAC. 
Means and standard deviations are shown from one representative experiment where all samples were derived 
from the same pre-culture. ** denotes P ≤ 0.01 (student’s t-test). All experiments were repeated 2 – 4 times from 
independent pre-cultures with similar results. (B) Influence of ROS on flocculation. Flocculation of cells was 
triggered by 30 µM FeCl3 in RPMI with or without 10 mM NAC. After 2 h incubation at 30 °C, sedimentation 
rates were determined as described in the experimental part. Means and standard deviations of three independent 
samples are shown (n = 3).  
3.2.3 C. albicans flocculation in response to high iron concentrations was dependent on 
both Hog1p and Pbs2p kinases       
We had observed that high iron concentrations induced a flocculent phenotype in WT cells 
(Figure 3.2.1). Thus, we investigated whether this phenotype was also dependent on the 
kinases Hog1p and Pbs2p. Interestingly, microscopic analysis and cell sedimentation assays 
showed that flocculation was absent in both Δhog1 and Δpbs2 mutants after exposure to high 
Fe
3+
, while it was still induced in the reference strain DAY286 (Figure 3.2.3A and B). When 
HOG1 was re-integrated as fusion protein with GFP (strain hAHGI, Table 1), flocculation 
was restored after exposure to high iron concentrations as shown by measuring cell 
sedimentation rates (Figure 3.2.3C). Thus, the induction of flocculation was dependent on 
HOG1 and PBS2. Moreover, we observed flocculation of Δhog1, when RPMI was 
supplemented with 10% human plasma (see Supplemental data 9). Thus, Δhog1 cells still had 
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the ability to aggregate. These two observations indicated that Hog1p was specifically 
required for the iron induced flocculent phenotype.  
 
Figure 3.2.3 - High iron mediated flocculation was absent in Δhog1 and Δpbs2 mutants.  
(A) Microscopic analysis of DAY286, Δhog1 (JMR114) and Δpbs2 (JJH31) upon exposure to 30 µM FeCl₃ at 30 
°C for 2 h. (B) Relative sedimentation rates of the reference strain (DAY286) and of Δhog1 (JMR114) and 
Δpbs2 (JJH31) mutants incubated in RPMI containing 30 µM FeCl3 or water (control) at 30 °C for 2 h. Means 
and standard deviations of three independent samples are shown (n = 3). *** denotes P < 0.001 (student’s t-test). 
(C) Relative sedimentation rates of the WT (SC5314), Δhog1 (CNC13) and Δhog1 + HOG1 (hAHGI) incubated 
in RPMI containing 30 µM FeCl3 or water (control) at 30 °C for 2 h. The hAHGI strain carries the HOG1 gene 
fused to GFP under control of the ACT1 promoter and integrated in the LEU2 locus (Arana et al, 2005). Means 
and standard deviations of three independent samples are shown (n = 3). *** denotes P < 0.001 (student’s t-test). 
To ensure that iron was taken up by Δhog1 and Δpbs2 cells, we determined Fe3+ levels in 
culture supernatants of the reference strain DAY286 and the deletion mutants Δhog1 and 
Δpbs2 after an incubation time of 15 min. All three strains removed iron with the same 
efficiency from the growth medium (Table 7). Moreover, we observed increased intracellular 
ROS generation in Δhog1 cells after incubation with 30 µM FeCl3 (see Supplemental data 10), 
indicating intracellular activity of iron and thus iron uptake by those cells. In agreement with 
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previous reports (Alonso-Monge et al, 2009), we observed higher basal ROS production in 
Δhog1 cells compared to DAY286 cells. 
Table 7 - Fe
3+ 
removal from growth medium by C. albicans strains. 
Strain Iron content of supernatant after 15 min at  
30 °C [% of starting conditions] 
DAY286 1.8 ± 0.8 
Δhog1 1.3 ± 0.47 
Δpbs2 2.6 ± 0.2 
Starting Fe
3+ 
concentrations of 30 µM were set as 100 %. 
3.2.4 Hog1p was activated by high iron concentrations  
As loss of HOG1 influenced the response of C. albicans to elevated iron concentrations we 
determined the phosphorylation (i.e. activation) state of Hog1p after exposure to high Fe
3+
 
concentrations. As shown in Fig 3.2.4A, we observed significant hyper-phosphorylation of 
Hog1p when the wild type strain SC5314 was exposed to 30 µM Fe
3+
. However, Hog1p 
hyper-phosphorylation was only transient, as maximum phosphorylation was obtained only 
from 7.5 - 10 min after exposure to high Fe
3+
 (Figure 3.2.4B). Results were similar, when the 
reference strain DAY286 was used (Figure 3.2.4C, D). Hog1p phosphorylation was almost as 
strong after exposure to high Fe
3+ 
concentrations as after exposure to sorbitol (positive 
control) (Figure 3.2.4C). But Hog1p was dephosphorylated already 15 min after the exposure 
to iron, while it was hyper-phosphorylated when sorbitol was used (Figure 3.2.4B and C).  
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Figure 3.2.4 - The HOG pathway was activated by exposure to high iron levels.  
(A) Western blot analysis of phosphorylated Hog1p (P-Hog1p) in C. albicans SC5314 (WT) cells exposed to 0 
or 30 µM FeCl3 in RPMI at 30 °C for 10 min. 5 µg total protein per sample were separated by SDS-PAGE. 
Phosphorylated Hog1p was detected by exposure of the membrane for 100 sec (for P-Hog1p) and 130 seconds 
(for Hog1p) after HRP reaction. (B) Western blot analysis of phosphorylated Hog1p in C. albicans SC5314 cells 
exposed to 30 µM or 1.2 µM FeCl3 in YNB medium for 7.5, 10 or 15 min at 30 °C. 16 µg total protein per 
sample were separated by SDS-PAGE. Phosphorylated Hog1p was detected by exposure of the membrane for 
100 sec (for P-Hog1p) and 130 seconds (for Hog1p) after HRP reaction. (C) Western blot analysis of 
phosphorylated Hog1p (P-Hog1p) in C. albicans DAY286 cells exposed to 0 or 30 µM FeCl3 in RPMI at 30 °C 
for 10 or 15 min. Sorbitol [1 M] was used as positive control. 12 µg total protein per sample were separated by 
SDS-PAGE. Phosphorylated Hog1p was detected by exposure of the membrane for 80 sec (for P-Hog1p) and 40 
seconds (for Hog1p) after HRP reaction. (D) Western blot analysis of phosphorylated Hog1p in C. albicans 
DAY286 cells exposed to 30 µM or 1.2 µM FeCl3 in YNB medium for 0, 5, 10 or 20 min at 30 °C. Procedures 
were the same as indicated above except the following: 16 µg protein per sample were loaded on the gel and the 
membrane was exposed for 20 sec (P-Hog1p) and 30 sec (Hog1p) respectively. The pictures were slightly 
rotated to obtain almost straight bands.  
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3.2.5 Hog1p was required for maintenance of C. albicans viability under high iron 
conditions 
Since Hog1p appeared to be involved in the response of C. albicans to high iron 
concentrations, we investigated whether Hog1p could have any protecting effect on C. 
albicans against deleterious effects of exposure to high iron levels. Thus, we determined the 
viability of cells after exposure to 30 µM Fe
3+
 using the alamarBlue
®
 assay, which is an 
indicator of the metabolic activity of cells (O'Brien et al, 2000). This fluorescence assay has 
been widely used to determine the viability of different yeasts including C. albicans (Fai & 
Grant, 2009; Pfaller & Barry, 1994; Pfaller et al, 1994). We observed that basal fluorescence 
signals were always higher for Δhog1 cells than for the reference strain DAY286 (see 
Supplemental data 11). This could be due to the intrinsically enhanced mitochondrial activity 
of HOG1 deficient cells (Alonso-Monge et al, 2009).  
Cells were exposed to 30 µM FeCl3 in RPMI and incubated at 30 °C for 60 min. A decrease 
of the reduction rate of alamarBlue®, i.e. of the viability, was observed for all tested strains. 
However, exposure to high iron levels led to a higher decrease of the signals obtained from 
the Δhog1 mutant (residual viability 46 ± 3%) compared to the reference strain (DAY286) 
(residual viability 81 ± 9.5%) and the wild type (SC5314) (residual viability 85%). These data 
indicate that the Δhog1 mutant was less resistant to high iron levels than the WT cells. 
However, after 2 days no apparent growth defects were observed when the strains SC5314 
(WT), DAY286 (reference strain), Δhog1 and Δpbs2 were grown on RPMI agar 
supplemented with 30 µM FeCl3 compared to cells grown on the same medium containing 0 
or 1 µM FeCl3, respectively (see Supplemental data 12). This could indicate that the reduced 
metabolic activity of the Δhog1 mutant observed 1 h after exposure to high iron 
concentrations did not affect growth of C. albicans on the long term.  
80 
 
The lower reduction rate of alamarBlue® after exposure of Δhog1 to high Fe3+ concentrations 
was probably not due to the more oxidized intracellular environment after exposure of Δhog1 
cells to high iron concentrations, as Δhog1 cells had a higher basal ROS level than WT cells, 
but the basal alamarBlue® signals were also higher. Thus, the intracellular oxidation state 
(indicated by the ROS level) did not directly correlate with alamarBlue® signals.   
3.2.6 MCFOs isolated by heat were regulated by iron availability  
The expression of genes involved in iron uptake is regulated by iron availability. High affinity 
iron uptake (HAIU) genes are induced in restricted iron conditions and repressed by high iron 
concentrations (Lan et al, 2004). As mentioned above, members of the corresponding protein 
families are present in the plasma membrane of C. albicans. Heating whole microbial cells 
resuspended in phosphate buffers to elevated temperatures was already described as a method 
for the extraction of proteins associated with the cell wall or with the plasma membrane of 
different microorganisms (Benz & Schmidt, 1992; Buck et al, 1984; Torres et al, 2002). 
Indeed, we could isolate members of the multicopper ferroxidase (MCFO) enzyme family by 
briefly boiling C. albicans cells grown in RPMI supplemented with 10% FBS at 30 °C.  
Proteins involved in HAIU are expected to be more abundant in cells cultivated in an iron 
restricted medium, such as RIM, compared to an iron sufficient medium (YPD). To determine 
whether the MCFO members isolated by heat were regulated by iron availability, we applied 
the heat extraction method on C. albicans SC5314 cells grown either under iron sufficient or 
iron restricted conditions. The extracted proteins were separated by SDS PAGE and 
visualized by coomassie staining. A protein band (80 - 100 kDa), which was significantly 
accumulated in RIM (Figure 3.2.5A), was cut from the gel/ blot and analyzed by MALDI-
TOF MS, MS/MS and N-terminal Edman degradation for identification. N-terminal 
sequencing of the protein extracted from the respective gel band resulted in the identification 
of the sequence KTHTxYYKTGxVNAN which corresponds to the N-terminal sequence of 
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the MCFO Fet3p (KTHTWYYKTGWVNAN) after cleavage of a predicted 20 amino acid 
signal peptide.  In the genome of C. albicans, five MCFO encoding genes are present. These 
are FET3 (orf19.4211), FET31 (orf19.4213), FET33 (orf19.943), FET34 (orf19.4215) and 
FET99 (orf19.4212). The K21 residue is unique for Fet3p among C. albicans MCFOs (Figure 
3.2.5B). Additionally, a glutamic acid peak appeared at residue 21, but was less intense than 
the lysine peak. This is indicative for the MCFOs Fet31p, Fet34p and Fet99p (Figure 3B). 
MALDI-TOF MS-analysis led to the identification of three peptide peaks specific for Fet34p 
and two peaks specific for Fet3p in addition to one peak shared between Fet34p and Fet3p, 
another peak shared between Fet3p, Fet31p and one peak shared between Fet3p, Fet31p and 
Fet99p (Table 8). MS-MS analysis of the peak appearing at 1384.7 m/z unequivocally 
confirmed the presence of Fet34p in the excised band. Taken together, these data indicated the 
presence of at least Fet3p and Fet34p in the protein extract. However, presence of Fet31p and 
Fet99p is also possible and could neither be confirmed nor excluded. In general, all C. 
albicans MCFOs apart from Fet33p, are highly conserved among each other as Fet31p, 
Fet34p and Fet99p have an identity ranging between 75 – 83 % compared to Fet3p (Almeida 
et al, 2009).  
Previous gene expression experiments in C. albicans had reported that FET34 expression was 
regulated by iron availability, as expression of this gene was induced by restricted iron 
compared to sufficient iron conditions (Hameed et al, 2011; Lan et al, 2004). Thus, we further 
investigated the dependence of the expression of extracted MCFOs on iron concentration in 
the growth medium. As RPMI is iron free, we used this medium as basis and added different 
amounts of FeCl3. Increasing ferric iron concentrations led to significant decreases of MCFOs 
levels as determined by SDS PAGE and subsequent coomassie staining of proteins (Figure 
3.2.5C). When iron concentrations equaled or exceeded 7.5 µM, hardly any protein band was 
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visible. Taken together, these results confirm that the expression levels of extracted MCFOs 
were dependent on the iron ion concentration in the growth medium. 
 
Figure 3.2.5 - MCFOs expression was regulated by iron levels.  
(A) SDS-PAGE analysis of proteins extracted by heating whole yeast cells of C. albicans SC5314. Cells were 
cultivated in sufficient iron (YPD) or restricted iron (RIM) medium at 30 °C for 5 h, and proteins were extracted 
as described in the experimental part. (B) Multiple sequence alignment (MSA) of the first 15 amino acids (aa) 
(given in the single letter code) after excision of a predicted 20 aa signaling peptide of MCFOs. The alignment 
was performed using CLUSTALW2 and displayed with the Jalview editor 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). The selected proteins are: Fet3p [UniProtKB: Q59NF9], Fet31p 
[UniProtKB: Q59NF7], Fet33 [UniProtKB: Q5A503], Fet34p [UniProtKB: Q59NF5] and Fet99p [UniProtKB: 
Q59NF8]. (C) SDS-PAGE analysis of MCFOs, which were extracted from cells grown in RPMI supplemented 
with different iron concentrations at 30 °C for 3 h.  
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Table 8 - Peptide peaks obtained from MS-MALDI-TOF analysis of the MCFOs band. 
Peptide peaks [m/z] MCFO 
  998.5 Fet3p 
1384.7  Fet34p 
1389.7 Fet3p 
1399.7 Fet34p 
1507.8 Fet3p, Fet31p 
1726.9 Fet3p, Fet34p 
1838.9 Fet34p 
1867.0 Fet3p, Fet31p, Fet99p 
 
3.2.7 Deletion of HOG1 induced components of the HAIU pathway independent of iron 
availability 
Previously, de-repression of genes involved in iron uptake (FET34, FTR1, FRE10 and RBT5) 
was reported in the Δhog1 mutant by whole genome gene expression profiling of cells grown 
under sufficient iron conditions (Enjalbert et al, 2006). As the expression of these genes is 
usually repressed by sufficient iron conditions and induced by restricted iron conditions (Lan 
et al, 2004) (for MCFOs see Figure 3.2.5), we investigated the function of Hog1p in the 
response of C. albicans to iron. We first confirmed elevated amounts of MCFO proteins in 
Δhog1 and Δpbs2 deletion mutants in comparison to the wild type (WT, SC5314) which was 
best seen in cells grown in YPD overnight (Figure 3.2.6A). The identity of the MCFO 
proteins was proven by MS/MS analysis of the peptide at 1726.9 m/z (not shown). Increased 
amounts of MCFOs were observed in two different, independently constructed Δhog1 and 
Δpbs2 mutants (see table 3 for the strains used in this study (Arana et al, 2005; San Jose et al, 
1996); data are shown for only one of the mutant strains). As proteins, which are usually used 
as gel loading controls, are cytosolic proteins and not present in the cell wall, we had added 
BSA to the extracted proteins to demonstrate that all lanes were loaded with the same total 
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amount of protein. However, the induction of MCFOs by low iron concentrations was not 
completely eliminated in the Δhog1 mutants, as we still observed induction of MCFOs 
expression (Figure 3.2.6B) when the Δhog1 mutant was cultivated in RIM compared to YPD. 
As FRE10, the major ferric reductase of C. albicans (Jeeves et al, 2011), was also reported to 
be de-repressed in the Δhog1 mutant (see above) (Enjalbert et al, 2006), we determined cell 
surface ferric reductase activity of whole yeast cells using a previously published protocol 
(Jeeves et al, 2011). As shown in Figure 3.6.2C, ferric reductase activities increased when the 
wild type (SC5314) and the reference strain (DAY286) were cultivated in RIM compared to 
YPD. This further highlights the induction of this class of proteins by low iron levels. 
Moreover, cell surface ferric reductase activity was increased in Δhog1 mutants compared to 
both SC5314 and DAY286 when cultivated in YPD (data are shown for only one of the 
mutant strains), showing that de-repression of these enzymes in Δhog1 mutants led to higher 
enzyme activities. Similar to the observations made before for MCFO levels, ferric reductase 
activity of the Δhog1 mutant was also increased in RIM compared to YPD. For confirmation, 
we cultivated all three strains (WT, DAY286 and Δhog1) in RPMI with or without 30 µM 
FeCl3 and made similar observations. Addition of iron to the RPMI medium led to a decrease 
in ferric reductase activity in all three strains (Figure 3.6.2D). 
Thus deletion of HOG1 led to both increased MCFOs expression as well as increased cell 
surface reductase activity, and both were further increased by iron restriction. 
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Figure 3.2.6 – Deletion of HOG1 led to de-repression of MCFOs and to increased ferric 
reductase activity.  
(A) SDS-PAGE analysis of MCFOs extracted from the WT (SC5314), Δhog1 (CNC13) and Δpbs2 (BRD3) 
mutants grown in YPD at 30 °C for 17 h. Identity of the MCFOs was confirmed by mass spectrometry. The gel 
was run for 30 min  at 80 V and 90 min at 120 V. (B) SDS-PAGE analysis of MCFOs extracted from Δhog1 
(JMR114) grown in sufficient iron (YPD) or restricted iron (RIM) medium at 30 °C for 3 h. was run for 3 h at 
120 V (excerpt of the Coomassie stained SDS-gel is shown). (C) Cell surface ferric reductase activity of SC5314 
(WT), DAY286 (reference strain) and Δhog1 (JMR114) under both restricted iron (RIM) and sufficient iron 
(YPD) conditions. Mean values and standard deviations of three independent experiments (n = 3) are shown. *** 
denotes P < 0.001 (student’s t-test). The ferric reductase of activity of the WT strain (SC5314) grown in YPD 
was set as 100%. (D) Cell surface ferric reductase activity of SC5314 (WT), DAY286 (reference strain) and 
Δhog1 (JMR114) under no iron (H2O) and high iron (30 µM FeCl3) conditions. Mean values and standard 
deviations of three independent experiments (n = 3) are shown. *** denotes P < 0.001 (student’s t-test). The 
ferric reductase of activity of the WT strain (SC5314) grown in YPD was set as 100%. 
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3.3.8 Identification of factors involved in the response to iron downstream of Hog1p 
Our data suggested that high iron induced flocculation of C. albicans cells was dependent on 
both, an intact HOG pathway and the synthesis of new proteins. The induction of flocculation 
suggests alterations of cell wall molecular organization. Flocculation was induced in C. 
albicans in response to the antimycotic compound caspofungin, which targets ß-(1,3)-glucan 
synthesis. This flocculent phenotype was dependent on the transcription factor Efg1p, which 
was required to activate the flocculine Als1p in response to caspofungin (Gregori et al, 2011). 
On the other hand, Tup1p is a transcriptional co-repressor known for inhibition of filamentous 
growth (Braun & Johnson, 1997), as well as an involvement in iron dependent responses of 
the cell (Knight et al, 2002).  
We investigated the phenotypic behavior of both Δefg1 and Δtup1 compared to the reference 
strain WT-arg. Both WT-arg and Δtup1 flocculated in response to 30 µM Fe3+ in a similar 
way as the WT. However, flocculation upon exposure to the same iron concentration was 
completely absent in Δefg1 (Figure 3.2.7), suggesting that Efg1p was required for induction 
of flocculation upon iron exposure, similar to Hog1p and Pbs2p.  
To confirm that Δefg1 had no iron uptake deficiency, we determined iron concentration in cell 
culture supernatants (see 2.6) of the reference strain WT-arg, Δefg1 and Δtup1 15 min after 
iron exposure. All three strains removed almost all iron from the supernatant with the same 
efficiency (not shown). 
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Figure 3.2.7 - High iron mediated flocculation was present in Δtup1 but absent in Δefg1 mutants.  
Relative sedimentation rates of the reference strain (WT-arg) and of Δefg1 (TF156) and Δtup1 (TF117) mutants 
incubated in RPMI containing 30 µM FeCl3 or water (control) at 30 °C for 2 h. Mean values and standard 
deviations of three independent samples are shown (n = 3). *** denotes P < 0.001 (student’s t-test). 
3.2.9 Discussion 
Previous studies on Δhog1 mutants from C. albicans and Cryptococcus neoformans showed 
that deletion of HOG1 led to the de-repression of several genes known to be upregulated 
under restricted iron conditions (Enjalbert et al, 2006; Ko et al, 2009). In C. albicans, this 
group of genes included RBT5, FRE10, FTR1, FET34, orf19.251, PMH7, ECM331, CAT1, 
DDR48, YOR009 and HSP12 (Chen et al, 2011; Enjalbert et al, 2006; Lan et al, 2004).  
Whether this phenotype was due to a direct involvement of Hog1p in the regulation of the 
iron responsive network or due to indirect effects, such as perturbations of copper 
metabolism, which may have impaired the functionality of iron uptake proteins was not yet 
studied. 
As expected, high levels of extracellular iron increased the formation of intracellular ROS. 
Thus, we used intracellular ROS levels together with the removal of iron from growth 
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medium as indicators of iron entry into the cells. We detected increased basal ROS levels in 
the Δhog1 mutants, as previously reported (Alonso-Monge et al, 2009). These ROS levels 
were further increased by exposure to 30 µM Fe
3+
 confirming that iron was taken up by 
Δhog1 cells. Moreover, iron ions were removed from the growth medium with the same 
efficiency by Δhog1 as by the reference (DAY286) cells. Thus, Hog1p dependent phenotypes 
of the C. albicans response to iron were not due to iron uptake deficiencies, but could be 
rather due to the involvement of Hog1p in the response to iron availability. This is supported 
by our data on the transient hyper-phosphorylation of Hog1p during exposure of cells to high 
iron concentrations. 
Elevated iron concentrations induced a flocculent phenotype of C. albicans, which was 
dependent on the presence of both Hog1p and Pbs2p, as well as on protein synthesis. As high 
iron concentrations led to increased phosphorylation of Hog1p, this could induce the synthesis 
of proteins of which some mediate cell aggregation. This iron triggered activation of Hog1p 
was likely not related to oxidative stress, as the potent radical scavenger NAC did not prevent 
the flocculent phenotype upon exposure to high iron concentrations, while it decreased 
intracellular ROS levels. For the closely related yeast S. cerevisiae, a function of ScHog1p in 
cell aggregation was reported, in that hyperactive ScHog1p mutants resulted in increased 
flocculation (Bell et al, 2001). Furthermore, the induction of flocculation is an indicator to 
changes in molecular organization of the cell wall. In a previous work (Gregori et al, 2011), 
the transcription factor Efg1p induced expression of Als1p leading to a flocculent phenotype 
in response to caspofungin exposure. Similarly, Efg1p was found in this work to be required 
for iron induced flocculation.  
It has still to be elucidated if Hog1p translocates to the nucleus upon hyper-activation by iron 
and whether iron activated Hog1p directly influences transcription and synthesis of new 
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proteins. Particularly, Efg1p could be activated by Hog1p and is thus a potential downstream 
factor in the network responsive to high iron concentrations.  
First hints on an involvement of Hog1p in the response of C. albicans to iron came from the 
observation of the de-repression of several iron uptake genes in the Δhog1 mutant under 
otherwise repressive conditions (Enjalbert et al, 2006). In agreement with these gene 
expression data, we observed increased MCFOs protein levels and ferric reductase activity in 
Δhog1 mutants. Furthermore we found that MCFOs were also de-repressed in Δpbs2 mutants, 
indicating that the HOG1 mediated regulation of MCFOs was dependent on PBS2. 
Remarkably, induction of MCFOs and ferric reductases in RIM was not strictly dependent on 
Hog1p, as this induction was also observed in the Δhog1 mutant. Thus deletion of HOG1 de-
repressed components of the iron uptake system, and this elevated basal level was further 
enhanced when iron availability was limited.  
Mass spectrometric and N-terminal sequencing analysis of protein bands in gels obtained 
from heat extracts of C. albicans identified at least Fet3p and Fet34p among the five possible 
MCFO gene products. The extracted MCFOs were collectively found to be regulated by iron 
availability, which is in line with data obtained from transcription analysis, as FET3 and 
FET34 were found to be upregulated during iron restriction in contrast to the other MCFO 
encoding genes (Cheng et al, 2013).   
Hog1p was shown to be essential for C. albicans under oxidative stress conditions (Alonso-
Monge et al, 2003). Our data indicated that the absence of HOG1 reduced the metabolic 
activity of the cells after exposure to high iron concentrations compared to wild type cells. 
Taking into account that exposure of Δhog1 cells to high iron concentrations further increased 
the comparably high basal intracellular ROS levels in the mutant, the decreased viability of 
the Δhog1 mutant under such conditions could be due to elevated oxidative stress. However, 
other mechanisms independent from Hog1p were also described for the initiation of oxidative 
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stress responses (Gonzalez-Parraga et al, 2010). These mechanisms could allow also the 
mutant strains to adapt to the stress conditions so that the reduced viability was observed only 
as immediate response and did not lead to significant growth defects on the long term. 
It has yet to be elucidated which elements downstream of Hog1p provide the link between the 
HOG pathway and factors which regulate reductive iron uptake. As many Hog1p repressed 
genes, including those involved in iron uptake (FET34, FRE10, FTR1 and RBT5), were also 
found to be repressed by Tup1p (Enjalbert et al, 2006), a role for this global co-repressor 
downstream of Hog1p could be assumed. Indeed, a role of Tup1p in regulating iron uptake 
has been reported (Knight et al, 2002). However, the details remain to be elucidated.   
In this study, we used several single gene deletion mutants which were generated by different 
approaches (Arana et al, 2005; Davis et al, 2002; Nobile & Mitchell, 2009; San Jose et al, 
1996). All mutant strains with exception of TF117, TF156 and WT-arg were descendants of 
the strain CAI-4 (Fonzi & Irwin, 1993), in which both copies of IRO1 are deleted. 
Additionally, all strains ectopically express URA3. 
 IRO1 is a gene that encodes a transcription factor with a potential role in iron utilization. 
Expression of IRO1 in a Δaft1 S. cerevisiae strain restored growth in iron depleted media. 
However, a role of IRO1 in C. albicans iron metabolism is not confirmed (Garcia et al, 2001). 
Ectopic expression of URA3 has been shown to affect several features of C. albicans, such as 
hyphal morphology, adhesion, virulence and cellular proteome in addition to Ura3p activity 
(Brand et al, 2004; Cheng et al, 2003). 
In all our experiments, the DAY286 reference strain behaved similar to the WT SC5314. 
Additionally, CNC13 and JMR114 (Δhog1) as well as BRD3 and JJH31 (Δpbs2) showed 
similar features. Thus, no effects of the ectopic expression of URA3 or the absence of IRO1 
were observed. 
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3.3 Effect of antifungal treatment on reductive iron uptake components of 
C. albicans with a special focus on fludioxonil  
3.3.1 Treatment of C. albicans cells by fludioxonil and iprodione repressed RIUP 
components independent of the HOG pathway  
As we found that Hog1p responds to changes in extracellular iron ion concentration on one 
hand and as RIUP components were de-repressed in Δhog1 cells on the other hand, we 
wondered whether the activation of Hog1p results in repression of iron uptake proteins 
expression. The repression of HAIU components under iron restricted conditions could be of 
high importance in fighting C. albicans infections. To study the effect of Hog1p activation on 
the RIUP system, represented by MCFOs expression and ferric reductase activity, we 
activated Hog1p by treatment of C. albicans DAY286 with the fungicides fludioxonil and 
iprodione (Figure 3.3.1A). Fludioxonil (a phenylpyrrole) and iprodione (a dicarboximide), 
target the histidine kinase (HK) Cos1p of C. albicans, which is upstream of the Hog1p MAPK 
module. Treatment of S. cerevisiae expressing C. albicans Cos1p with both antifungals has 
led to the activation of Hog1p in this yeast (Buschart et al, 2012b). Moreover, fludioxonil 
physically interacts with C. albicans Cos1p, confirming that this HK is a receptor of 
fludioxonil (Mohammed El-Mowafy, BISA, personal communication).  
Addition of 20 µg ml
-1
 of each antifungal to YPD as well as to RIM, led to a significant 
repression of MCFOs expression (Figure 3.3.1B and C). However, addition of fludioxonil to 
RIM decreased MCFO levels also in Δhog1 cells (Figure 3.3.1D).  
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Figure 3.3.1 – Treatment of C. albicans with fludioxonil or iprodione led to repression of RIUP 
components independently of Hog1p.  
RIM was prepared by adding 200 µM BPS to YPD resulting in iron restricted conditions. (A) Western blot 
analysis of phosphorylated Hog1p in C. albicans DAY286 treated with fludioxonil or iprodione (at 20 µg ml
-1 
final concentration each) or MeOH (solvent control; i.e. without the addition of fludioxonil or iprodione) in both 
YPD (iron sufficient) and RIM (iron restricted) at 30 °C. Blot was exposed for 10 sec (P-Hog1p) and 20 sec 
(Hog1p) respectively. (B) Excerpt of coomassie stained SDS gel showing MCFOs from C. albicans DAY286 
cells treated with fludioxonil [20 µg  ml
-1
] or MeOH in both YPD and RIM (3 h at 30 °C). The gel was run for 3 
h at 120 V. (C) Excerpt of coomassie stained SDS gel showing MCFOs from C. albicans DAY286 cells treated 
with iprodione [20 µg  ml
-1
] or MeOH in both YPD and RIM (3 h at 30 °C). The gel was run for 3 h at 120 V. 
(D) Excerpt of coomassie stained SDS gel showing MCFOs from C. albicans Δhog1 cells (JMR114) treated with 
fludioxonil [20 µg  ml
-1
] or MeOH in both YPD and RIM (3 h at 30 °C). The gel was run for 3 h at 120 V. (E) 
Cell surface ferric reductase activity of C. albicans DAY286 and Δhog1 (JMR114) treated with fludioxonil [20 
µg ml
-1
], or MeOH. Mean values and standard deviations of three independent experiments (n = 3) are shown. * 
denotes P ≤ 0.05 (student’s t-test). The ferric reductase of activity of the MeOH (solvent) treated reference 
strains (DAY286) grown in YPD was set as 100%. Fdx: fludioxonil; Ipro: iprodione. Bovine serum albumin 
(BSA) was added to protein extracts shown in B - D as internal standard to serve as a loading control. 
Furthermore, fludioxonil treatment decreased ferric reductase activity of cells in both, the 
sufficient iron (YPD) and the restricted iron medium (RIM). This was observed for both, the 
reference strain (DAY286) as well as the Δhog1 mutant (Figure 3.3.1E).  
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To confirm that such observations were independent of genetic background of DAY286 cells, 
ferric reductase activity of SC5314 cells was determined in RIM. Fludioxonil was found to 
decrease ferric reductase activity by ca. 50% (see Supplemental data 13).   
These results indicated that fludioxonil targeted reductive iron uptake pathway (RIUP) 
components independent on Hog1p. 
To determine whether repression of RIUP components by the antifungals occurred in a Cos1p 
independent manner, we analyzed ferric reductase activity and MCFO levels in a Δcos1 
deletion mutant after fludioxonil or iprodione treatment. Total surface ferric reductase activity 
of Δcos1 cells was significantly decreased by fludioxonil in RIM (See Supplemental data 
14A). Furthermore, treatment of Δcos1 cells with fludioxonil and iprodione repressed MCFOs 
expression under both, iron sufficient (YPD) and iron restricted (RIM) conditions (See 
Supplemental data 14B). These results clearly showed that fludioxonil and iprodione acted on 
the RIUP in a Cos1p independent manner.   
A number of antifungal compounds of different classes, including the azole antifungal 
ketoconazole, were reported to cause downregulation of genes encoding iron uptake proteins 
(Liu et al, 2005). Combination of the azole antifungal fluconazole with several iron binding 
molecules or serum has been widely reported to increase antifungal activity of fluconazole on 
C. albicans (Fiori & Van Dijck, 2012; Kobayashi et al, 2011; Minn et al, 1997; Wakabayashi 
et al, 1998). Thus, we determined ferric reductase activity of fluconazole treated cells. 
Fluconazole (20 µg ml
-1
) significantly decreased ferric reductase activity of cells in RIM 
compared to MeOH control (See Supplemental data 13), while having no apparent effect on 
growth during incubation time (not shown). In a different experiment, a lower fluconazole 
concentration (10 µg ml
-1
) also decreased ferric reductase activity as did fludioxonil and 
iprodione (See Supplemental data 15). 
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3.3.2 Repression of RIUP components by fludioxonil was independent on Sfu1p 
We wondered whether fludioxonil perturbed cellular iron homeostasis thus simulating 
conditions of iron overload as suggested for amphotericin B (Liu et al, 2005). Sfu1p is the 
negative transcriptional regulator of several iron uptake genes, including MCFO and ferric 
reductase encoding genes (Lan et al, 2004; Homann et al, 2009; Chen et al, 2011) and is 
believed to act as iron sensor (Pelletier et al, 2007).  Therefore, we analyzed MCFO levels of 
the Δsfu1 mutant in RIM medium after fludioxonil treatment. Fludioxonil was found to 
repress MCFOs expression under these conditions in the Δsfu1 mutant as well as the in 
corresponding reference strain WT-arg (Figure 3.3.2). Furthermore, MCFOs were de-
repressed in Δsfu1cells (in comparison with WT-arg), complying with previous knowledge on 
the role of Sfu1p in repressing HAIU components (Lan et al, 2004; Chen et al, 2011). This 
experiment indicated that repression of MCFOs expression by fludioxonil was not dependent 
on Sfu1p.  
 
Figure 3.3.2 – Repression of MCFOs by fludioxonil was independent of Sfu1p transcriptional 
repressor.  
(A) Excerpt of coomassie stained SDS gel showing MCFOs from C. albicans Δcos1 cells treated with 
fludioxonil [20 µg  ml
-1
] or MeOH in RIM (3 h at 30 °C). Fdx: fludioxonil. Bovine serum albumin (BSA) was 
added to protein extracts as internal standard to serve as a loading control. Gel was run for 3 h and 15 min at 120 
V. This experiment was performed only once. 
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3.3.3 Fludioxonil reduced growth of C. albicans SC5314 under iron restricted conditions 
As fludioxonil repressed RIUP components even under iron restricted conditions, where these 
components are normally induced, we speculated whether fludioxonil treatment would have 
any effect on C. albicans growth under conditions of iron restriction. C. albicans SC5314 was 
pre-cultivated in YPD (iron repleted) or YPD + 400 µM BPS (iron depleted) before cells were 
dropped on agar plates of different media comprising a fermentable (glucose or galactose) or 
a non-fermentable (glycerol) carbon source. The agar plates were incubated at 30 °C for 16 h. 
Figure 3.3.3 summarizes the results of C. albicans SC5314 under these conditions. 
Fludioxonil alone had little effect on C. albicans growth in YPD. Restricting iron availability 
by 200 µM BPS slightly reduced C. albicans growth compared to YPD. However, addition of 
fludioxonil led to a significant growth reduction. No differential behavior was observed 
between cells which were pre-cultivated under iron depleted or repleted conditions (Figure 
3.3.3A). When glucose was substituted by galactose (YP-galactose medium), no clear 
reduction in growth was observed in fludioxonil treated cells compared to solvent control. In 
contrast to this, iron restriction significantly reduced growth and addition of fludioxonil 
almost prevented growth, especially of cells which were pre-cultivated in iron depleted 
medium (Figure 3.3.3B). Similarly to galactose, cells exhibited a significant decrease of 
growth under iron restricted conditions when grown on glycerol as carbon source. Fludioxonil 
further aggravated the effect of iron restriction on C. albicans growth under iron restricted 
conditions, while it had again no clear effect when under sufficient iron conditions (Figure 
3.3.3C). Taken together these results indicate that fludioxonil treatment enhanced the effect of 
iron restriction on C. albicans growth, probably by repression of high affinity iron uptake 
(HAIU) components which are required under such conditions. This effect was independent 
from the ability of C. albicans to use the available carbon source for fermentation.  
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Figure 3.3.3 – Fludioxonil treatment aggravated the effect of iron restriction on C. albicans 
growth. 
(A) Growth test of C. albicans SC5314 on YPD agar plates supplemented with either the phenylpyrrole 
antifungal fludioxonil (Fdx; 20 µg ml
-1
) or the iron chelator BPS (200 µM) or both. (B) Growth test of C. 
albicans SC5314 on YP-galactose agar plates supplemented either with fludioxonil (Fdx; 20 µg ml
-1
) or BPS 
(200 µM) or both. (C) Growth test of C. albicans SC5314 on YP-glycerol agar plates supplemented either with 
fludioxonil (Fdx; 20 µg ml
-1
) or BPS (200 µM) or both. All plates were incubated at 30 °C for 16 h. Two 
replicate plates for each treatment are shown. Only first three serial dilutions (1:1 – 1:102) of cells are shown. 
“Iron depleted” refers to the cells being pre-cultivated in YPD + 400 µM BPS at 30 °C for 7 h, while “iron 
repleted” refers to the cells being pre-cultivated in YPD at 30 °C for 7 h.   
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3.3.4 Fludioxonil induced flocculation of C. albicans 
The repression of RIUP components by fludioxonil under iron restricted conditions could 
reduce the availability of HAIU proteins on the cell surface and thus lead to decreased iron 
uptake. To determine whether fludioxonil treatment caused reduced iron uptake, we 
investigated the effect of fludioxonil on the uptake of iron from transferrin, the major iron 
binding protein in human serum. The RIUP of C. albicans was previously shown to be 
required for iron uptake from transferrin (Knight et al, 2005). However, experiments could 
not be properly performed, as fludioxonil induced flocculation of cells in RPMI medium after 
ca. 3 h of incubation at 30 °C. This prevented correct counting of cell numbers in order to 
calculate relative iron uptake pro cell.  
Induction of flocculation by fludioxonil was found to be dependent on Hog1p as Δhog1 cells 
lost the ability to form flocs in contrast to SC5314 and DAY286 cells (Figure 3.3.4). 
However, although flocs were formed in SC5314 and DAY286 after fludioxonil treatment, 
the influence of fludioxonil concentration on flocculation was not reproducible. In some 
cases, same fludioxonil concentrations led to visibly different degrees of flocculation in 
independent tests (not shown).   
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Figure 3.3.4 – Fludioxonil treatment induced flocculation of C. albicans. 
Microscopic analysis of SC5314, DAY286 and Δhog1 (JMR114) after exposure to different fludioxonil (Fdx) 
concentrations in RPMI medium at 30 °C for 4 h (starting OD600 = 0.32). Figure represents one single 
experiment.  
3.3.5 Discussion 
Fludioxonil treatment of DAY286 led to reduced MCFO levels and ferric reductase activity. 
Remarkably, the same observation was made in Δhog1 and Δcos1 deletion mutants pointing 
to fludioxonil mediated effects independent of the HOG pathway.  
The existence of Cos1p- (and thus HOG pathway) independent effects of fludioxonil were 
recently reported by our group (Buschart et al, 2012a). However, it is still elusive why 
fludioxonil and iprodione behaved similarly in Δcos1 or Δhog1 deletion mutants, as both 
antifungals potentially share the intracellular target, Cos1p (Buschart et al, 2012b), but belong 
to different compound classes. Fluconazole had a similar decreasing effect on ferric reductase 
activity of WT cells as fludioxonil and iprodione. Other compounds, such as amphotericin B 
ketoconazole or casponfungin, have been shown to downregulate iron uptake genes at the 
transcriptional level (Liu et al, 2005). This points to influences which are not specific for a 
certain chemical class of compounds, as most of these compounds are chemically not related 
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to each other and have different modes of action. Fluconazole inhibits the activity of the 
cytochrome P450 dependent Lanosterol 14-alpha-demethylase (P450-DM), which is 
responsible for ergosterol synthesis in C. albicans (Vanden Bossche et al, 1995). In C. 
albicans, P450-DM is the gene product of ERG11. Iron restriction has been shown to 
downregulate ERG11 leading to a decrease in ergosterol content of cell membranes thus 
increasing membrane fluidity (Prasad et al, 2006). Furthermore, P450-DM activity requires 
heme iron (Vanden Bossche et al, 1995). It has been reported that combination of iron binding 
molecules or serum with fluconazole treatment has led to increased susceptibility of C. 
albicans to fluconazole (Fiori & Van Dijck, 2012; Kobayashi et al, 2011; Minn et al, 1997; 
Wakabayashi et al, 1998). As C. albicans upregulates ERG11 as a defense mechanism upon 
exposure to fluconazole (Henry et al, 2000), it is likely that iron restriction reverses this effect 
by Hap43p mediated repression of iron utilizing genes (Chen et al, 2011) leading to increased 
fluconazole susceptibility. Furthermore, the decrease of ferric reductase activity by 
fluconazole (Supplemental data 13) suggests a decrease of the high affinity iron uptake 
capacity, which is required during restricted iron conditions. Thus, increased susceptibility of 
C. albicans to fluconazole could be due to additive factors which reduce both iron uptake and 
ergosterol synthesis.  
Furthermore, it should be noted that if membrane properties are altered by the combined 
effect of iron restriction and fluconazole treatment, this could lead to the improper integration 
of membrane associated proteins into the membrane, such as RIUP components (Figure 1.4). 
For this reason, potential regulation of RIUP components by fluconazole should be studied at 
the transcriptional level. 
The action of fludioxonil under restricted iron conditions could be, at least in part, analogous 
to that of fluconazole. However, currently no other target of fludioxonil than Cos1p is known 
in C. albicans and our results suggest a Cos1p independent effect of fludioxonil in repressing 
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RIUP components. Fludioxonil reversed induction of RIUP components under restricted iron 
conditions. Repression of MCFOs by fludioxonil also occurred in Δsfu1 cells suggesting that 
fludioxonil treatment did not simulate a situation of intracellular iron overload. In agreement 
of previous knowledge at the transcriptional level (Chen et al, 2011; Homann et al, 2009), the 
de-repression of MCFOs in Δsfu1 cells compared to the reference strain (WT-arg) was 
observed in solvent (MeOH) treated cells. This reduces the probability of improper integration 
of MCFOs into the cell membrane by fludioxonil treatment.    
The fludioxonil mediated repression of RIUP components reduces the availability of proteins 
involved in high affinity iron uptake. As such proteins are induced under iron restricted 
conditions, this suggests that fludioxonil treated cells may suffer from decreased iron uptake 
during iron limitation. This could explain the slightly reduced growth of C. albicans on BPS 
and fludioxonil supplemented plates. However, effects of fludioxonil on growth of iron 
deprived cells were more apparent when cells grew on glycerol, which is a non-fermentable 
carbon source (Askew et al, 2009). In this case, cells would be dependent on respiration for 
providing energy, and restricted iron conditions lead to the Hap43p mediated downregulation 
of genes of iron utilizing proteins, including genes of the respiratory chain. This would 
explain the poor growth of C.albicans on BPS supplemented YP-glycerol plates. Similar 
observations were also made with growth on galactose. The poor growth of C. albicans YP-
galactose supplemented with BPS may in this case point to an effect similar to the “Kluyver-
effect”, known from other yeasts, which describes poor metabolization of galactose or other 
sugars under anaerobic conditions (Goffrini et al, 2002). Furthermore, the expression of 
GAL1, encoding for the first enzyme in galactose metabolism (Askew et al, 2009), was found 
to be repressed by Hap43p under iron restricted conditions (Singh et al, 2011). Fludioxonil 
treatment reduced growth further, as fewer proteins with high affinity to iron would be 
available on the cell surface leading to decreased iron uptake. This hypothesis is further 
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strengthened by the slightly protective effect of pre-cultivating cells in iron repleted 
conditions (YPD), compared to iron depleted conditions (YPD + 400 µM BPS) seen upon 
growth on galactose and to a lesser extent on glycerol while being absent upon growth on 
glucose (Figure 3.3.3).      
The induction of flocculation by fludioxonil points to altered cell wall organization. As in the 
case of iron, fludioxonil dependent flocculation seemed to be dependent on Hog1p. However, 
flocculation in response to 20 µg ml
-1
 fludioxonil in RPMI medium could only be observed 
after 3 – 4 h of incubation at 30 °C. Unfortunately, no concentration dependent effects could 
be observed as intensity of flocculation visibly changed for the same concentration between 
different cultivations. The irreproducibility of results regarding concentration dependency 
prevented further characterization of this phenomenon. However, fludioxonil mediated 
flocculation could be therapeutically useful if flocs cause a reduced adhesion of C. albicans 
cells to host tissues.    
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Chapter 4 Conclusion and outlook 
We have produced two synthetic peptides (a10 and a7/8) resembling predicted alpha-helices 
in the antigenic C. albicans cell wall protein Bgl2p, which were used for monoclonal antibody 
production by immunization in Balb/c mice. We have expressed and purified a recombinant 
variant of Bgl2p lacking the signal peptide (rBgl2p-SP) in E. coli under non- denaturing 
conditions. This variant of the protein could be bound by anti-a10 or anti-a7/8 antibodies 
present in hybridoma cell culture supernatants. Moreover, anti-a10 antibodies from two 
supernatants, C25HD4H4 and C25HD4H8, could bind to SC5314, DAY286 cells but not to 
Δbgl2 cells as determined by flow cytometry analysis. Thus, the anti-a10 antibodies contained 
in C25HD4H4 or C25HD4H8 provide promising tools for early clinical diagnosis of C. 
albicans cells. However, full evaluation of the specificity and sensitivity of the two antibodies 
described above was not possible within the time of this thesis. Once purified anti-a10 
antibodies are available, flow cytometric analysis should be repeated and the antibodies 
should be tested with other pathogens to determine potential cross reactivities. Conditional 
expression of Bgl2p in Δbgl2 cells (Park & Morschhauser, 2005) and subsequent analysis of 
antibody binding to transformants should also confirm the specificity of antibodies for Bgl2p.  
This thesis reports for the first time in fungi, that the conserved stress activated MAPK Hog1p 
of C. albicans is involved in the response to changes in extracellular iron levels. Previous 
studies had only shown that deletion of HOG1 led to the de-repression of HAIU components 
in this fungus under otherwise repressive conditions. We found that repression of high affinity 
iron uptake (HAIU) components of the reductive pathway by Hog1p occurs independently of 
environmental iron availability. Exposure of C. albicans to high iron concentrations renders 
Hog1p hyper-phosphorylated. Thus, these results suggest that Hog1p plays a dual role in C. 
albicans iron homeostasis: on the one hand basal Hog1p activity permanently reduces 
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expression of HAIU components and on the other hand hyper-activity of Hog1p leads to the 
activation of a specific response towards high iron concentrations. It has yet to be elucidated 
which elements downstream of Hog1p provide the link between the HOG pathway and factors 
which regulate reductive iron uptake, with Efg1p appearing as a putative component. 
Figure 4.1.1 summarizes the currently known intracellular events upon exposure of C. 
albicans to high iron concentrations.   
This thesis further describes new findings related to the effect of fludioxonil on C. albicans 
growth under iron restricted conditions as well as on expression and activity of RIUP 
components. This could be of high value for C. albicans treatment, as targeting iron uptake 
pathways is considered as an attractive approach for fighting microbial pathogens.  
Combination of therapeutically applied iron binding molecules, such as lactoferrin, 
deferroxamine or genistein, with fludioxonil or iprodione could be investigated for its effect 
on C. albicans growth. The main idea behind this is to create conditions of iron restriction 
while simultaneously preventing C. albicans from full utilization of its high affinity iron 
uptake machinery. This could be of great importance for patients suffering from iron 
overload, which are at high risk of acquiring C. albicans infections.    
The repression of RIUP components by fludioxonil occurred independently of Sfu1p. This 
indicates a complex regulation of these iron uptake proteins. This would lead to the 
conclusion that MCFOs are not suitable targets for diagnostic approaches. 
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Figure 4.1.1 – Exposure of C. albicans to high iron concentrations. 
Current knowledge of intracellular events upon exposure of C. albicans to high iron concentrations (30 µM Fe
3+
) 
is summarized herewith. Fe
3+
 is rapidly removed from the growth medium (within 15 minutes) and enters the 
cell leading to accumulation of reactive oxygen species (ROS). This means that Fe
3+ 
is, at least partly, 
intracellularly reduced to Fe
2+
. Genes encoding high affinity iron uptake proteins are repressed by Sfu1p (Chen 
et al, 2011) which is thought to act as an iron sensor (Pelletier et al, 2007). High iron concentrations induce 
hyper-phosphorylation of the MAPK Hog1p. It is still unknown whether this happens in a direct or indirect 
fashion. The high iron concentrations lead to the induction of flocculation of C. albicans cells. This is dependent 
on an intact HOG pathway as well as on synthesis of new proteins, but is rather not related to ROS 
accumulation. Transcription factors (TFs) and flocculins that could mediate flocculation are still to be identified. 
One potential transcription factor downstream of Hog1 could be Efg1p (not included in the figure), as Efg1p was 
also required for iron induced flocculation.    
Effects of fludioxonil on the regulation of RIUP components should be studied at the 
transcriptional level. This could help to ascertain whether fludioxonil mediated repression of 
MCFOs and decrease of ferric reductase activity, are due post-transcriptional regulation, such 
as blocking of trafficking or proper integration of the respective proteins to the cell 
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membrane. However, an initial experiment on the Δsfu1 mutant did not support this 
suggestion (3.3.2). 
Dissecting changes which occur in the cell wall upon exposure to high iron or to fludioxonil, 
leading to the induction of flocculation are of great interest. The induction of flocculation by 
fludioxonil could be interesting because it may inhibit or decrease C. albicans adhesion to 
host cells, as binding sites of adhesins of may be occupied or shielded by floc formation. 
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Chapter 5 Supplemental data 
Supplemental data 1 
Ca_BGL2_ FLAG3x_His8x sequence (Ca_BGL2) in alignment with the BGL2 WT nucleotide 
sequence (>orf19.4565|BGL2).  
>orf19.4565|BGL2 was obtained from the CGD (www.candidagenome.org). Alignment was 
performed using ClustalW2 and displayed with Jalview. Stop codon, restriction sites used for 
cloning and signal peptide coding sequence are indicated.    
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Supplemental data 2 
Extraction of cell surface proteins by several methods from both whole and disrupted cells. 
  
SDS-PAGE analysis of coomassie stained C. albicans cell surface proteins. (A) proteins 
extracted from CAF2-1 cell walls by Zymolyase treatment (20 U ml
-1
). 48 µg total protein 
was loaded on gel. Gel ran for 25 min at 80 V and 3 h 17 min at 120 V. three Bgl2p peaks 
were identified by MALDI-TOF MS analysis: 1142.5 m/z, 1267.69 m/z and 3057.441 m/z. 
(B) proteins extracted from cell walls by Zymolyase treatment. Lane 1: extracts from 
DAY286. Lane 2: extracts from Δbgl2 (FB63-3). 43 µg total protein was loaded on gel for 
each extract. Gel ran for 1 h at 80 V and 1 h at 120 V. Bgl2p was identified in DAY286 
extract by comparison with an equally treated extract from Δbgl2 in addition to molecular 
size. (C) Proteins extracted from cell walls by treatment with 12 M urea at 90 °C. Lane 1: 
extracts from DAY286. Lane 2: extracts from Δbgl2 (FB63-1). 50 µg total protein was loaded 
on gel for each extract. Gel ran for 3 h and 20 min at 80 V. Bgl2p was identified in DAY286 
extract by comparison with an equally treated extract from Δbgl2 in addition to molecular 
size. (D) Proteins extracted from CAF2-1 cell walls by treatment with 2% SDS in 5 mM Tris 
HCl pH 7.5 at 90 °C. 15 µg total protein was loaded on gel. Presence of Bgl2p could not be 
confirmed by MALDI-TOF MS or MS/ MS analysis. Following proteins could be identified 
by MALDI-TOF MS and subsequent mascot search (http://www.matrixscience.com/) instead: 
Tef1p (orf19.1435; peaks 1364.7 m/z, 1560.8 m/z, 1677.9 and 2493.1 m/z), Adh1p 
(orf19.3997; peaks 1103.6 m/z, and 1271.6 m/z), Atp1p (orf19.6854; peaks 1273.7 m/z and 
1553.8 m/z), Tdh3p (orf19.6814; peaks 1145.6 m/z, 1500.8 m/z and 1766.8 m/z) and Rps4p 
(orf19.5341; peak1199.6 m/z). (E) Proteins extracted from CAF2-1 cell walls at 90 °C in 5 
mM Tris HCl pH 7.5. 24 µg total protein was loaded on gel. Presence of Bgl2p could be 
confirmed by MS/ MS analysis. (F) Proteins extracted from whole SC5314 cells (grown in 
RPMI + 10% FBS at 30 °C for 5 h) at 90 °C in PBS. 38 µg total protein was loaded on gel. 
Gel ran for 2 h and 20 min at 120 V. Presence of multicopper ferroxidase (MCFO) members 
was confirmed by MALDI-TOF-MS analysis (see below) and N-terminal sequencing 
(KTHTWYYKTGxV). 
 
Peptide peaks [m/z] MCFO 
1384.7  Fet34p 
1726.9 Fet3p, Fet34p 
1838.9 Fet34p 
1867.0 Fet3p, Fet31p, Fet99p 
3107.5 Fet3p 
4056.9 Fet34p 
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Supplemental data 3 
Microscopic analysis of C. albicans DAY286 grown in RPMI + 10% FBS at 37 °C for 3 h. 
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Supplemental data 4 
Multiple sequence alignment (MSA) of Bgl2p orthologues from three different C. albicans 
strains (SC5314, WO-1 and ATCC10261) and six different non-albicans Candida species.  
Cdu: C. dubliniensis, Cgl: C. glabrata, Ctr: C. tropicalis, Cgu: C. guilliermondii, Clu: C. 
lusitaniae (Clu), Cpa: C. parapsilosis. See 2.10 for details. Alignment was performed with 
ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) (default settings) and displayed with 
Jalview.  
 
Alignment scores are listed in the table below compared to the sequence of the C. albicans 
SC5314 orthologue. Note that N-terminal fragments of the C. lusitaniae and C. parapsilosis 
orthologues were missing*. 
Strain/ Organism Length (aa) Alignment score 
SC5314 308 100 
WO-1 308 100 
ATCC10261 308 99 
C. dubliniensis 308 95 
C. parapsilosis 228* 74 
C. guilliermondii 307 70 
C. lusitaniae 227* 70 
C. glabrata 308 65 
C. tropicalis 309 60 
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Supplemental data 5 
NCBI basic local alignment search tool (BLAST) results for peptides a10 and a7/8 
respectively in bacteria, fungi (excluding the Candida clade*), archaea and humans.  
Following criteria were applied to determine a relevant hit:  
(i) No gaps were allowed between peptide and hit-sequence in the alignment 
(ii) Query coverage (QC) between peptide and hit-sequence must be at least 80%. 
(iii) Identity (I) and similarity (S) between peptide and hit-sequence must be at least 
80%.  
(iv) The E-value was set at 1000. 
(v) The score was calculated according to the PAM-30 substitution matrix. 
 
BLAST was performed by Yvonne Mayer (Microdiscovery GmbH, Berlin).  
 
Hits for peptide a10 
Organism Protein ID QC I S E-Value Score 
Cellulomonas flavigena 
DSM 20109 
YP 003635918: glycoside 
hydrolase family 10 
93 54 85 613.16 52.0 
Hits for peptide a7/8 
Organism Protein ID QC I S E-Value Score 
Lodderomyces elongisporus 
NRRL YB-4239 
XP 001524413: glucan 1,3-
beta-glucosidase precursor 
100 82 82 2.38719E-5 110.0 
Scheffersomyces stipitis CBS 
6054, Pichia stipitis CBS 
6054 
XP 001387556: Glycoside 
hydrolase, family 17 
100 82 82 4.29787E-5 108.0 
Pichia guilliermondii ATCC 
6260 
EDK38288: hypothetical 
protein PGUG 02386 
100 82 82 6.05893E-4 99.0 
Meyerozyma guilliermondii 
ATCC 6260 
XP 001484657: hypothetical 
protein PGUG 02386 
100 82 82 6.05893E-4 99.0 
Debaryomyces hansenii 
CBS767,  
Debaryomyces hansenii 
XP 462355: DEHA2G18766p 100 76 82 0.00109084 97.0 
Yarrowia lipolytica XP 500465: YALI0B03564p 100 71 82 0.00263517 94.0 
Clavispora lusitaniae ATCC 
42720 
XP 002614964: hypothetical 
protein CLUG 04979 
100 71 82 0.00636586 91.0 
Please note that Lodderomyces elongisporus, Pichia (Meyerozyma) (Candida) guilliermondii, 
Debaryomyces hansenii and Clavispora (Candida) lusitaniae belong to the Candida clade 
(see Figure 1.1). 
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Supplemental data 6 
Dot blot analysis of supernatants binding to rBgl2-SP 
rBgl2p-SP was expressed and purified under non-denaturing conditions and 96 ng were 
dropped on PVDF membranes. Membranes were blocked and washed with TBS containing 
0.05% (v/v) Tween-20. Membranes were incubated overnight with C25JA11B10 or 
C26FC11F7 and subsequently with HRP-linked secondary antibody. Membranes were later 
stripped and treated with anti-FLAG antibody. Blots were exposed for 100 sec each. 
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Supplemental data 7 
Microscopic analysis of the reference strain (DAY286) after exposure to 30 µM or 1.2 µM 
FeCl3 in YNB. Cells were incubated at 30 °C for 2 h.  
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Supplemental data 8 
Synthesis of new proteins is required for induction of flocculation in DAY286 upon exposure 
to 30 µM Fe
3+
. 
 
(A) Relative sedimentation rates of DAY286 cells treated with cycloheximide (CHX) C. 
albicans DAY286 was pre-treated either with 500 µg ml
-1
 CHX or MeOH in RPMI at 30 °C 
for 15 min. Iron or water were subsequently added and cells were incubated at 30 °C for 2 h. 
Sedimentation rates were determined as described in the experimental part. Means and 
standard deviations of three independent samples are shown (n = 3). ** denotes P ≤ 0.01 
(student’s t-test). (B) Microscopic analysis of CHX or MeOH pre-treated cells (see A). 
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Supplemental data 9 
Flocculation is induced in the Δhog1 mutant by exposure to 10% human plasma. 
 
Microscopic analysis of DAY286 or Δhog1 (JMR114) cells incubated in RPMI supplemented 
with 10% human plasma at 30 °C for 2 h 30 min.  
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Supplemental data 10 
Exposure to high iron concentrations led to intracellular ROS accumulation in Δhog1 cells. 
 
Experiments for ROS accumulation in Δhog1 cells were performed twice (n = 2). Means and 
standard deviations are shown of one representative experiment where all samples were 
derived from the same pre-culture. *** denotes P < 0.001 (student’s t-test).    
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Supplemental data 11 
Cell viability measurement by alamarBlue® 
Relative fluorescence units (RFU) obtained for SC5314, DAY286 and Δhog1 (JMR114) 1 h 
after exposure to 30 µM FeCl3 or H2O control at 30 °C. Results for DAY286 and Δhog1 
(JMR114) are shown as means of three independent experiments. Experiment for SC5314 was 
performed only once. 
 
Sample RFU 
SC5314 H2O control 6207.67 
SC5314 30 µM FeCl3 5302.67 
DAY286 H2O control 4656.44 ± 358.51 
DAY286 30 µM FeCl3 3777.22 ± 428 
Δhog1 H2O control 9424.66 ± 758.8 
Δhog1 30 µM FeCl3 4370.55 ± 358.5 
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Supplemental data 12 
Growth tests of several C. albicans strains of solid RPMI medium containing different 
concentrations. 
The WT (SC5314), the reference strain (DAY286), and the Δhog1 (JMR114) and Δpbs2 
(JJH31) mutants were diluted in YPD each to ca. 0.5 · 106 cells ml-1 and further diluted in 1:10 
steps. 5 µl of each cell suspension were dropped on RPMI agar plates containing 0 (RPMI), 1 
or 30 µM FeCl3. Plates were incubated for 2 d at 30 °C before pictures were taken. All plates 
were prepared in triplicates and one representative for each plate is shown.  
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Supplemental data 13 
Ferric reductase activity was decreased in SC5314 after fludioxonil treatment under restricted 
iron conditions 
 
Cell surface ferric reductase activity of C. albicans SC5314 treated with MeOH, fludioxonil 
or fluconazole in RIM medium. Mean values and standard deviations of three independent 
experiments (n = 3) are shown. *** denotes P ≤ 0.001 (student’s t-test). The ferric reductase 
of activity of the MeOH (solvent) treated culture set as 100%.  
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Supplemental data 14 
Repression of RIUP components by fludioxonil is independent of the fludioxonil receptor, 
histidine kinase Cos1p. 
 
(A) Cell surface ferric reductase activity of C. albicans Δcos1 (JJH37) treated with 
fludioxonil [20 µg ml
-1
], or MeOH in RIM medium. Mean values and standard deviations of 
three independent experiments (n = 3) are shown. *** denotes P ≤ 0.001 (student’s t-test). The 
ferric reductase of activity of the MeOH (solvent) treated culture set as 100%. (B) Excerpt of 
coomassie stained SDS gel showing MCFOs from C. albicans Δcos1 cells treated with 
fludioxonil or iprodione [each at 20 µg ml
-1 
final concentration] or MeOH in both YPD and 
RIM (3 h at 30 °C). Fdx: fludioxonil; ipro: iprodione. Bovine serum albumin (BSA) was 
added to protein extracts shown in B as internal standard to serve as a loading control. Gel ran 
for 3 h at 120 V. 
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Supplemental data 15 
Ferric reductase activity of SC5314 treated with MeOH, fludioxonil, iprodione or fluconazole 
under restricted iron conditions 
 
Cell surface ferric reductase activity of C. albicans SC5314 treated with MeOH, fludioxonil 
(Fdx), iprodione (Ipro) or fluconazole (Flu) in RIM medium. Cells were resuspended in 1.5 
ml RIM supplemented with the respective antifungal/ MeOH and cultivated in a 24 well plate 
(30 °C, 3 h, 550 rpm) in an Eppendorf comfort 5355R thermomixer. Experiment was 
performed only once. 
Antifungal [concentration] Ferric reductase activity 
(% of RIM + MeOH) 
YPD + MeOH 40.28 
RIM + MeOH 100 
RIM + Fdx [20 µg ml
-1
] 64.28 
RIM + Ipro [20 µg ml
-1
] 74.14 
RIM + Flc [10 µg ml
-1
] 47.24 
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